Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G1B,Phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,50528,-0.0851698752687916,0.0274113926553075,-0.138896204873194,-0.031443545664389,0.00189175250832502
PLA2G1B,Phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,48305,-0.0289423326650685,0.0303562093463075,-0.0884405029838313,0.0305558376536942,0.340387079826349
PLA2G1B,Phospholipase A2,Physical activities,X1070.Time spent watching television (TV),51349,-0.0375884495979715,0.0272996894519203,-0.0910958409237352,0.0159189417277922,0.168562298867853
PLA2G1B,Phospholipase A2,Physical activities,X1080.Time spent using computer,48333,-0.00612127048446659,0.0269309026929516,-0.0589058397626518,0.0466632987937186,0.820196399257095
PLA2G1B,Phospholipase A2,Physical activities,X1090.Time spent driving,45574,-0.0516121371205808,0.0294272847004033,-0.109289615133371,0.00606534089220957,0.0794678890040216
PLA2G1B,Phospholipase A2,Lifestyle factors,X1160.Sleep duration,52425,-0.0116007592198599,0.0247937176833485,-0.0601964458792229,0.0369949274395031,0.639866766279621
PLA2G1B,Phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,36107,-0.0378757101343043,0.0175799068050533,-0.0723323274722087,-0.00341909279639986,0.0312335845481505
PLA2G1B,Phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,36107,-0.010963443586268,0.0193116795613598,-0.0488143355265333,0.0268874483539973,0.570248526673415
PLA2G1B,Phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,36107,0.000745318414999687,0.0204472258296258,-0.0393312442110669,0.0408218810410663,0.970923851349662
PLA2G1B,Phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,36107,0.0201510933103848,0.0210465378388178,-0.0211001208536981,0.0614023074744676,0.338368951302809
PLA2G1B,Phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,36107,0.0438405221874006,0.0215552563586758,0.00159221972439593,0.0860888246504052,0.0420001088206407
PLA2G1B,Phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,36107,0.0728813293373521,0.0569117230526416,-0.0386656478458255,0.18442830652053,0.200372672140022
PLA2G1B,Phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,36107,0.100541291533251,0.0665057084985244,-0.0298098971238572,0.230892480190358,0.130634642303362
PLA2G1B,Phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,36107,-0.00222732134612645,0.0340397310057166,-0.068945194117331,0.064490551425078,0.947831001211268
PLA2G1B,Phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,36107,0.0180955462852983,0.0260801941381794,-0.0330216342255333,0.0692127267961298,0.487802474679712
PLA2G1B,Phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,36107,3.02509876725837e-05,0.0176555428761037,-0.0345746130494907,0.0346351150248359,0.998632951669906
PLA2G1B,Phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,36107,0.0514824917577919,0.0280018675722675,-0.00340116868385242,0.106366152199436,0.0660226791938133
PLA2G1B,Phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,36107,-0.0063572618686321,0.0131584259799575,-0.0321477767893488,0.0194332530520846,0.629015822574349
PLA2G1B,Phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,36107,0.0217168733440327,0.0180074803994323,-0.0135777882388546,0.0570115349269201,0.227858667224889
PLA2G1B,Phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,36107,0.00680570748633778,0.0284971539449137,-0.0490487142456931,0.0626601292183687,0.811251212640681
PLA2G1B,Phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,36107,0.0388680003541464,0.0264282429127336,-0.0129313557548115,0.0906673564631042,0.141414347113741
PLA2G1B,Phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,36107,0.0634801134818766,0.0324561303361521,-0.000133901976981432,0.127094128940735,0.0505169916292024
PLA2G1B,Phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,36107,0.0380554467920958,0.0314883596962798,-0.0236617382126126,0.0997726317968041,0.226871526272276
PLA2G1B,Phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,36107,-0.00798664419239808,0.0201550339392393,-0.0474905107133071,0.0315172223285109,0.691924112697588
PLA2G1B,Phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,36107,-0.00198432391673231,0.0196765486486433,-0.0405503592680731,0.0365817114346085,0.919674487865674
PLA2G1B,Phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,36107,-0.00328094109126368,0.021867438631172,-0.0461411208083607,0.0395792386258334,0.880738870099593
PLA2G1B,Phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,36111,-0.0231323097819001,0.0479723669333736,-0.117158148971312,0.0708935294075122,0.629677421444548
PLA2G1B,Phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,36114,0.00563293244760069,0.0477034728643838,-0.0878658743665916,0.099131739261793,0.906005660553865
PLA2G1B,Phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,36114,-0.0299930028120051,0.0520745395738899,-0.132059100376829,0.072073094752819,0.564657512819789
PLA2G1B,Phospholipase A2,Health and medical history,X120098.Mobility problems today,36116,-0.0205337282401809,0.0549814843784726,-0.128297437621987,0.0872299811416253,0.708812004524599
PLA2G1B,Phospholipase A2,Health and medical history,X120099.Self-care problems today,36116,-0.0921545226896192,0.08184706831185,-0.252574776580845,0.0682657312016069,0.260228770965744
PLA2G1B,Phospholipase A2,Health and medical history,X120100.Problems doing usual activities,36116,-0.018210657833843,0.0529833333543099,-0.12205799120829,0.0856366755406045,0.731077467046239
PLA2G1B,Phospholipase A2,Health and medical history,X120101.Pain or discomfort today,36116,-0.032144390334379,0.0479989582656363,-0.126222348535026,0.0619335678662682,0.503076433677488
PLA2G1B,Phospholipase A2,Health and medical history,X120102.Anxiety or depression today,36116,0.0356566585705752,0.061510023423125,-0.0849029873387499,0.1562163044799,0.562142023177558
PLA2G1B,Phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,36098,-0.00665456493552029,0.00575264685654444,-0.0179297527743474,0.00462062290330682,0.247397821478247
PLA2G1B,Phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,36100,-0.0172798438348802,0.0599041793841759,-0.134692035427865,0.100132347758104,0.773004097600093
PLA2G1B,Phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",36098,0.0425047415540548,0.0641531210579827,-0.0832353757195913,0.168244858827701,0.507638261240891
PLA2G1B,Phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",36104,0.0382710647430675,0.0484064300370513,-0.056605538129553,0.133147667615688,0.429191089451969
PLA2G1B,Phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,36109,-0.0212795197289202,0.0489726788955696,-0.117265970364237,0.0747069309063963,0.663924678566244
PLA2G1B,Phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,36108,0.0689192874632041,0.0711624725605637,-0.0705591587555009,0.208397733681909,0.332836917023048
PLA2G1B,Phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,36091,-0.00897242777017179,0.0680952266604388,-0.142439072024632,0.124494216484288,0.895175334182029
PLA2G1B,Phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,36111,-0.0306613515836739,0.0643259278203417,-0.156740170111544,0.0954174669441959,0.633620835091206
PLA2G1B,Phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,36103,-0.0220395938949281,0.0920256067391492,-0.202409783103661,0.158330595313804,0.810728980493729
PLA2G1B,Phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,36068,0.157457587670325,0.132790918788415,-0.102812613154969,0.417727788495619,0.235756530488609
PLA2G1B,Phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33264,0.0615128800704282,0.066876823307091,-0.0695656936114702,0.192591453752327,0.357728170005894
PLA2G1B,Phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49875,-0.0604086199171077,0.0595738798737271,-0.177173424469613,0.0563561846353975,0.310588631815198
PLA2G1B,Phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48632,-0.0726387407004,0.0345035232036654,-0.140265646179584,-0.00501183522121572,0.0352814694013004
PLA2G1B,Phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51475,-0.0200503291941864,0.0258685051828355,-0.0707525993525439,0.0306519409641712,0.438296559327364
PLA2G1B,Phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50629,-0.0564607016269702,0.0265538447994384,-0.108506237433869,-0.00441516582007099,0.0334916900005799
PLA2G1B,Phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51337,0.0690194697071533,0.0271324752297971,0.0158398182567509,0.122199121157556,0.0109720851725219
PLA2G1B,Phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,50329,0.0773683435532804,0.0287031606564194,0.0211101486666984,0.133626538439862,0.00703447131901531
PLA2G1B,Phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52573,-0.0114139106414633,0.0523869438634523,-0.11409232061383,0.0912644993309032,0.827526795581109
PLA2G1B,Phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52574,0.02097783939319,0.0258653996895214,-0.029718343998272,0.0716740227846519,0.417351515024682
PLA2G1B,Phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52574,0.0532168826245431,0.0247225823989869,0.00476062112252869,0.101673144126558,0.0313630940722849
PLA2G1B,Phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52574,0.0686410431899812,0.0253788616217722,0.0188984744113078,0.118383611968655,0.00684238159800688
PLA2G1B,Phospholipase A2,Diet and food preferences,X1438.Bread intake,52020,0.00521334831054517,0.00328249984231,-0.00122035138038242,0.0116470480014728,0.112248969048533
PLA2G1B,Phospholipase A2,Diet and food preferences,X1458.Cereal intake,51351,0.215526930215569,0.0257900139760922,0.164978502822429,0.26607535760871,6.79764312196175e-17
PLA2G1B,Phospholipase A2,Diet and food preferences,X1488.Tea intake,51697,0.0230291265957687,0.00322979107437724,0.0166987360899893,0.0293595171015481,1.03158564084111e-12
PLA2G1B,Phospholipase A2,Diet and food preferences,X1498.Coffee intake,50713,-0.119892483851422,0.0256199747358308,-0.17010763433365,-0.0696773333691934,2.89068724069784e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X1528.Water intake,50392,0.00791116293216593,0.02589159755847,-0.0428363682824353,0.0586586941467672,0.759950645907982
PLA2G1B,Phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,46860,-0.144869706946686,0.0288854027372297,-0.201485096311656,-0.0882543175817154,5.3440089988403e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46851,-0.051543785361741,0.0300109338812235,-0.110365215768939,0.00727764504545709,0.0859047801146577
PLA2G1B,Phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46926,-0.148931583775282,0.0300331223116435,-0.207796503506103,-0.0900666640444606,7.15233143190553e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,46854,-0.0820013423721235,0.0310030095296197,-0.142767241050178,-0.0212354436940689,0.00817734670481668
PLA2G1B,Phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,46895,-0.0254139106831678,0.0552394431136863,-0.133683219185993,0.0828553978196573,0.645472742623617
PLA2G1B,Phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,46250,-0.0570597177053778,0.030470401402315,-0.116781704453915,0.00266226904315946,0.0611363331151182
PLA2G1B,Phospholipase A2,Health and medical history,X1807.Father's age at death,46449,0.00477867717336513,0.00376436833045362,-0.00259948475432396,0.0121568391010542,0.204297183403429
PLA2G1B,Phospholipase A2,Health and medical history,X1845.Mother's age,37431,0.00365308023375132,0.0080978643125023,-0.0122187338187532,0.0195248942862558,0.651916660451591
PLA2G1B,Phospholipase A2,Health and medical history,X1873.Number of full brothers,52161,-0.0417951364450363,0.0248899358273293,-0.0905794106666017,0.00698913777652904,0.0931266748207641
PLA2G1B,Phospholipase A2,Health and medical history,X1883.Number of full sisters,52163,0.0496138579040798,0.0248554027548156,0.000897268504641231,0.0983304473035184,0.0459345781826438
PLA2G1B,Phospholipase A2,Physical measures,X20015.Sitting height,52361,-0.02060866417821,0.00422484215782136,-0.0288893548075398,-0.0123279735488801,1.07874917786822e-06
PLA2G1B,Phospholipase A2,Cognitive function,X20016.Fluid intelligence score,36277,-0.0484873885184335,0.0408745437267207,-0.128601494222806,0.031626717185939,0.235560730474654
PLA2G1B,Phospholipase A2,Cognitive function,X20018.Prospective memory result,36628,-0.0725211100768861,0.0527701032012541,-0.175950512351344,0.0309082921975719,0.169391890330825
PLA2G1B,Phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36190,0.00248431497852534,0.00583332276867241,-0.00894899764807258,0.0139176276051233,0.670204931885894
PLA2G1B,Phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36191,0.00909718197125243,0.00584572666220636,-0.00236044228667204,0.0205548062291769,0.119699702215318
PLA2G1B,Phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,52263,0.00693891334343791,0.00332872834907931,0.000414605779242458,0.0134632209076334,0.037120517680448
PLA2G1B,Phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49071,0.00667832433862152,0.00736651646149112,-0.00776004792590108,0.0211166966031441,0.364640485588097
PLA2G1B,Phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48618,-0.0295239654625291,0.0165752750331134,-0.0620115045274314,0.00296357360237319,0.0748940988469985
PLA2G1B,Phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48577,-0.0236294091011002,0.0217967484431464,-0.0663510360496672,0.0190922178474667,0.278342615230322
PLA2G1B,Phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48602,-0.0182759119740868,0.0195443792834438,-0.0565828953696367,0.0200310714214631,0.349749033375966
PLA2G1B,Phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48623,0.0142378379993522,0.0130616968334718,-0.0113630877942526,0.039838763792957,0.275706417075912
PLA2G1B,Phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48798,-0.00600226339586131,0.00938677279058189,-0.0244003380654018,0.0123958112736792,0.522544997651443
PLA2G1B,Phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48745,4.46384161697758e-06,0.0119059721258328,-0.0233312415250153,0.0233401692082493,0.999700857184335
PLA2G1B,Phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48637,0.00366606121508966,0.0144818864180516,-0.0247184361642915,0.0320505585944708,0.800156411213874
PLA2G1B,Phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48767,-0.0103340747073006,0.0111467250520463,-0.0321816558093114,0.0115135063947102,0.353888230040787
PLA2G1B,Phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48858,0.0103885760473921,0.00832068243943092,-0.00591996153389253,0.0266971136286767,0.211853463200115
PLA2G1B,Phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48711,-0.0293157817309495,0.0114565168761127,-0.0517705548081303,-0.00686100865376861,0.0105084365501616
PLA2G1B,Phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49876,0.0274669734355808,0.00877118931211353,0.0102754423838383,0.0446585044873234,0.00174151784599671
PLA2G1B,Phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49716,-0.00611486053656119,0.0122811444400343,-0.0301859036390283,0.017956182565906,0.618555194414962
PLA2G1B,Phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49636,-0.0161447991488461,0.0273793271472706,-0.0698082803574965,0.0375186820598043,0.555417478022243
PLA2G1B,Phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49671,0.0148942001031779,0.0145913545738076,-0.0137048548614849,0.0434932550678407,0.307382184796387
PLA2G1B,Phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49821,0.0057694396595089,0.00983257304363404,-0.0135024035060138,0.0250412828250316,0.557365742840166
PLA2G1B,Phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49714,-0.0104536099879467,0.0164621258533594,-0.0427193766605312,0.0218121566846377,0.52542895435055
PLA2G1B,Phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49680,-0.0045683585774277,0.014945912348694,-0.0338623467808678,0.0247256296260124,0.7598670081683
PLA2G1B,Phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49689,-0.011775569073255,0.0125150030393316,-0.0363049750303449,0.0127538368838349,0.34675858357471
PLA2G1B,Phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49724,-0.00357809387646685,0.014992482690819,-0.0329633599504721,0.0258071721975384,0.811372173872593
PLA2G1B,Phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49929,-0.000523967454417888,0.00753153340481476,-0.0152857729278548,0.014237838019019,0.944536707770642
PLA2G1B,Phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49774,-0.0233908841606323,0.0113341645131562,-0.0456058466064184,-0.00117592171484624,0.03905356459983
PLA2G1B,Phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46776,0.0100182444800128,0.0120481778308896,-0.0135961840685309,0.0336326730285565,0.405693499068281
PLA2G1B,Phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46627,-0.00569078498883868,0.0485376974742128,-0.100824672038296,0.0894431020606184,0.906667497377151
PLA2G1B,Phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46620,-0.00715889752591055,0.0477997204083734,-0.100846349526322,0.0865285544745013,0.880948854303336
PLA2G1B,Phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46675,-0.00403019265542735,0.0157494587232277,-0.0348991317529537,0.026838746442099,0.79803556708605
PLA2G1B,Phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46637,-0.0430369892853165,0.0279835913024132,-0.0978848282380463,0.0118108496674133,0.124081658282188
PLA2G1B,Phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46671,-0.0134488907499975,0.0201494929907999,-0.0529418970119653,0.0260441155119702,0.504489721875294
PLA2G1B,Phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46642,0.0319289008699109,0.0230863732257533,-0.0133203906525656,0.0771781923923873,0.166676047963542
PLA2G1B,Phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46644,-0.0119008693849502,0.0224416774741515,-0.0558865572342871,0.0320848184643867,0.595908995179276
PLA2G1B,Phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46653,-0.00311628571671724,0.0177944190153466,-0.0379933469867965,0.0317607755533621,0.860981696872608
PLA2G1B,Phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46670,0.0248699698381458,0.0224953095621191,-0.0192208369036076,0.0689607765798992,0.268930663809722
PLA2G1B,Phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46840,-0.00170125772891166,0.0091589399234579,-0.0196527799788891,0.0162502645210658,0.852644197069898
PLA2G1B,Phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46741,-0.0409859429269705,0.0127795227091687,-0.0660338074369412,-0.0159380784169998,0.00134286116746552
PLA2G1B,Phospholipase A2,Mental health,X20127.Neuroticism score,47919,0.0256134445051005,0.0257302447575365,-0.024817835219671,0.076044724229872,0.319524779883666
PLA2G1B,Phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36277,-0.0607670989648862,0.041507722580049,-0.142122235221782,0.0205880372920098,0.143236313115214
PLA2G1B,Phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,36960,-0.0253873265073007,0.00577710389245372,-0.03671045013651,-0.0140642028780914,1.12412475475094e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36960,-0.0261227633648032,0.00569520314389487,-0.0372853615268371,-0.0149601652027693,4.56640151445703e-06
PLA2G1B,Phospholipase A2,Cognitive function,X20191.Fluid intelligence score,34296,-0.00793821396461208,0.0496650217591043,-0.105281656612456,0.0894052286832323,0.873016649149413
PLA2G1B,Phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34297,-0.0241258605831629,0.0508288469656286,-0.123750400635795,0.0754986794694692,0.63505541754672
PLA2G1B,Phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,33749,0.0163849760684938,0.0531550222611031,-0.0877988675632683,0.120568819700256,0.757905449786588
PLA2G1B,Phospholipase A2,Physical measures,X20255.Spirometry QC measure,45726,-0.0189862620991715,0.0318872988869152,-0.0814853679175253,0.0435128437191824,0.551572165003617
PLA2G1B,Phospholipase A2,Eye measures,X20261.avMSE,33874,-0.0144422847453485,0.0072084168436292,-0.0285707817588618,-0.000313787731835302,0.0451714151503092
PLA2G1B,Phospholipase A2,Eye measures,X20262.Myopia diagnosis,33874,0.116477114110983,0.0618731611151234,-0.00479428167465909,0.237748509896625,0.0598212253554927
PLA2G1B,Phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,42271,-0.0459936499569239,0.00421217390133666,-0.0542495108035438,-0.0377377891103041,1.21333490270619e-27
PLA2G1B,Phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42296,-0.012298728579611,0.00446722090025021,-0.0210544815441015,-0.00354297561512064,0.00591107157770476
PLA2G1B,Phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36024,0.00773894630950026,0.0273402521834559,-0.0458479479700734,0.0613258405890739,0.777138328236091
PLA2G1B,Phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36024,-0.0623403698695925,0.0601792112411207,-0.180291623902189,0.0556108841630041,0.300276917442123
PLA2G1B,Phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36024,0.0950099809433452,0.073592335560604,-0.0492309967554387,0.239250958642129,0.196733153751589
PLA2G1B,Phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36024,0.0151834805450806,0.0266871232755372,-0.0371232810749724,0.0674902421651335,0.569411307082078
PLA2G1B,Phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36024,0.0251893092731441,0.0378380239786392,-0.0489732177249886,0.0993518362712769,0.505614487902543
PLA2G1B,Phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36027,0.0895860717489159,0.0513556288360118,-0.0110709607696671,0.190243104267499,0.0811262766125955
PLA2G1B,Phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36027,0.0222390210049357,0.0322197077606663,-0.0409116062059703,0.0853896482158417,0.49007089161525
PLA2G1B,Phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36027,0.026556533474317,0.0369221857902086,-0.0458109506744919,0.0989240176231258,0.472005333410148
PLA2G1B,Phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36027,-0.000738376016777846,0.053693771260938,-0.105978167688216,0.104501415654661,0.989028514673956
PLA2G1B,Phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36027,0.0600009644522634,0.0597618901690778,-0.057132340279129,0.177134269183656,0.315411106901429
PLA2G1B,Phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36027,0.0287023670881283,0.0389059737612536,-0.0475533414839287,0.104958075660185,0.460697735667987
PLA2G1B,Phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36027,0.127135233035273,0.0581425646779274,0.0131758062665349,0.24109465980401,0.0288019506333812
PLA2G1B,Phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36027,0.138983064208314,0.0473994328695046,0.0460801757840845,0.231885952632543,0.00337633003676994
PLA2G1B,Phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36030,0.068272385750201,0.0797820929959607,-0.0881005165218819,0.224645288022284,0.392171579392395
PLA2G1B,Phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36030,0.0268496156674132,0.035250368208204,-0.0422411060206668,0.0959403373554931,0.446273239203115
PLA2G1B,Phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36030,0.0538805968465811,0.0462951502490284,-0.0368578976415146,0.144619091334677,0.244522297635366
PLA2G1B,Phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36030,-0.055838217296459,0.0977668113965846,-0.247461167633765,0.135784733040847,0.567924234270814
PLA2G1B,Phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,36707,-0.0359030142185513,0.0421699525898025,-0.118556121294564,0.0467500928574617,0.394578732654606
PLA2G1B,Phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,36707,-0.0713983720164632,0.0421691397808726,-0.154049885986974,0.011253141954047,0.0904667667108251
PLA2G1B,Phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,36707,0.120184904019425,0.0428913911978315,0.036117777271675,0.204252030767175,0.00508956198605705
PLA2G1B,Phospholipase A2,Diet and food preferences,X20603.Liking for apples,36707,-0.019637209872476,0.0433678675651256,-0.104638230300122,0.0653638105551702,0.650700918247837
PLA2G1B,Phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,36707,-0.0768509354186943,0.0426690531091822,-0.160482279512692,0.00678040867530288,0.0717254012695546
PLA2G1B,Phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,36707,-0.062791428640606,0.0423996631109964,-0.145894768338159,0.020311911056947,0.138661018312176
PLA2G1B,Phospholipase A2,Diet and food preferences,X20606.Liking for avocados,36707,-0.070560863177639,0.0422834042990621,-0.153436335603801,0.0123146092485227,0.09520356570511
PLA2G1B,Phospholipase A2,Diet and food preferences,X20607.Liking for bacon,36707,-0.0914578162432938,0.0435085863009686,-0.176734645393192,-0.0061809870933953,0.0355785055107168
PLA2G1B,Phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36707,-0.110224790939377,0.042409998873052,-0.193348388730559,-0.0271011931481952,0.00936575685300085
PLA2G1B,Phospholipase A2,Diet and food preferences,X20609.Liking for bananas,36707,0.000954942548047933,0.0435626849444731,-0.0844279199431194,0.0863378050392152,0.982511423006658
PLA2G1B,Phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36707,-0.156584694366264,0.0427198781255371,-0.240315655492317,-0.0728537332402113,0.000248548884176163
PLA2G1B,Phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,36707,-0.164366508591677,0.0429643762333117,-0.248576686008968,-0.0801563311743864,0.00013140974177202
PLA2G1B,Phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,36707,-0.147940064658686,0.042131608159473,-0.230518016651253,-0.065362112666119,0.00044821513407521
PLA2G1B,Phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,36707,-0.110484461749307,0.0424402344498445,-0.193667321271003,-0.0273016022276121,0.00925008059072981
PLA2G1B,Phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,36707,0.0234812833349177,0.0426859400972036,-0.0601831592556013,0.107145725925437,0.582270012359955
PLA2G1B,Phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,36707,0.143083516999592,0.0428445523251802,0.0591081944422389,0.227058839556945,0.000842792033949906
PLA2G1B,Phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,36707,-0.13835280831806,0.0427435805720478,-0.222130226239274,-0.0545753903968465,0.00121360581179293
PLA2G1B,Phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,36707,-0.141854315398277,0.0427302219797706,-0.225605550478627,-0.0581030803179262,0.000904911866585502
PLA2G1B,Phospholipase A2,Diet and food preferences,X20618.Liking for black olives,36707,-0.139269402061822,0.0427582449374396,-0.223075562139204,-0.0554632419844406,0.00113006054360814
PLA2G1B,Phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,36707,-0.182806237610551,0.0431744213898792,-0.267428103534714,-0.0981843716863876,2.31971208018851e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,36707,-0.168029947662863,0.0423834921014664,-0.251101592181737,-0.0849583031439891,7.41783214930106e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,36707,-0.0924813919579342,0.04278349017847,-0.176337032707735,-0.0086257512081331,0.0306771464352926
PLA2G1B,Phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,36707,-0.0796709048784761,0.0428024992746056,-0.163563803456703,0.00422199369975092,0.0627294142590526
PLA2G1B,Phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,36707,-0.131445655150579,0.0433705574230499,-0.216451947699756,-0.0464393626014008,0.00244711390386327
PLA2G1B,Phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,36707,0.0143276660046411,0.0425592705868532,-0.0690885043455911,0.0977438363548733,0.736387931852981
PLA2G1B,Phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,36707,-0.0781847900253345,0.0422838390730473,-0.161061114608507,0.00469153455783819,0.0644875018742995
PLA2G1B,Phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),36707,-0.0510856176924064,0.0423056673561,-0.134004725710362,0.0318334903255496,0.227261043876566
PLA2G1B,Phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36707,-0.136498597447505,0.0425123737419697,-0.219822849981765,-0.0531743449132441,0.0013288437323992
PLA2G1B,Phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,36707,-0.0250886370030376,0.0428590259250498,-0.109092327816135,0.05891505381006,0.558311361853251
PLA2G1B,Phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,36707,0.0358663834463285,0.0424062894381637,-0.0472499438524723,0.118982710745129,0.397700580223071
PLA2G1B,Phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,36707,-0.183817634556623,0.0424706471713763,-0.26706010301252,-0.100575166100725,1.52202367711758e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20631.Liking for cake,36707,0.194079316627381,0.0424681053448536,0.110841830151468,0.277316803103294,4.94946604415382e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,36707,0.142477356189407,0.0422984106891093,0.0595724712387528,0.225382241140061,0.000759624008309728
PLA2G1B,Phospholipase A2,Diet and food preferences,X20633.Liking for capers,36707,-0.134279574883019,0.0419114111931726,-0.216425940821638,-0.052133208944401,0.00136109288815381
PLA2G1B,Phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,36707,-0.134094080730589,0.0427301784782513,-0.217845230547962,-0.0503429309132166,0.00170623037939751
PLA2G1B,Phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36707,0.0819558959385989,0.0425093977138096,-0.00136252358046789,0.165274315457666,0.0538965564335942
PLA2G1B,Phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,36707,0.0311149030130758,0.0426074683919964,-0.0523957350352371,0.114625541061389,0.465247046245011
PLA2G1B,Phospholipase A2,Diet and food preferences,X20637.Liking for cherries,36707,-0.0622502407829309,0.0429988860940968,-0.146528057527361,0.0220275759614989,0.147734779559376
PLA2G1B,Phospholipase A2,Diet and food preferences,X20638.Liking for chicken,36707,-0.0237325553772554,0.0437084369792889,-0.109401091856662,0.0619359811021509,0.587162482191241
PLA2G1B,Phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,36707,-0.15311749322532,0.0423855208184969,-0.236193114029573,-0.0700418724210655,0.000305101402134785
PLA2G1B,Phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,36707,-0.0290026491983821,0.0430759867108487,-0.113431583151646,0.0554262847548812,0.500781760124003
PLA2G1B,Phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,36707,0.0263180240642463,0.0656548684808687,-0.102365518158256,0.155001566286749,0.68853811127976
PLA2G1B,Phospholipase A2,Diet and food preferences,X20642.Liking for cod,36707,-0.0967789981471246,0.0436275561829842,-0.182289008265774,-0.0112689880284756,0.0265620317183632
PLA2G1B,Phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,36707,0.111075754010197,0.0438398742439272,0.0251496004920996,0.197001907528294,0.0113062102411308
PLA2G1B,Phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,36707,-0.135679759988962,0.0426545959443741,-0.219282768039935,-0.0520767519379887,0.00147375107450794
PLA2G1B,Phospholipase A2,Diet and food preferences,X20645.Liking for coriander,36707,-0.145095934103258,0.0422678845221932,-0.227940987766756,-0.062250880439759,0.000600438071470951
PLA2G1B,Phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,36707,0.122377194164501,0.0423732793075661,0.0393255667216715,0.205428821607331,0.00388634864516704
PLA2G1B,Phospholipase A2,Diet and food preferences,X20647.Liking for cream,36707,0.0578936985184395,0.0421949131803059,-0.02480833131496,0.140595728351839,0.170084640159329
PLA2G1B,Phospholipase A2,Diet and food preferences,X20648.Liking for croissant,36707,0.00748978488244889,0.0420983113951676,-0.0750229054520796,0.0900024752169773,0.858796721147155
PLA2G1B,Phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,36707,-0.0714125995419517,0.0426047314700301,-0.154917873223211,0.0120926741393073,0.0937442963279888
PLA2G1B,Phospholipase A2,Diet and food preferences,X20650.Liking for curry,36707,-0.0716827386076857,0.0430174028454046,-0.155996848184679,0.0126313709693074,0.0956792075254571
PLA2G1B,Phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,36707,0.0532739964294884,0.0427813234745621,-0.0305773975806534,0.13712539043963,0.213071146659173
PLA2G1B,Phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,36707,0.0561422688316544,0.042488488594446,-0.0271351688134599,0.139419706476769,0.186421201391221
PLA2G1B,Phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36707,-0.0157323639177557,0.0429790169932185,-0.0999712372244639,0.0685065093889525,0.714339155489303
PLA2G1B,Phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,36707,-0.0944368509466816,0.0428486520462361,-0.178420208957304,-0.0104534929360589,0.027554968767964
PLA2G1B,Phospholipase A2,Diet and food preferences,X20655.Liking for eggs,36707,-0.0409391884361737,0.0435932157028546,-0.126381891213769,0.0445035143414212,0.347697997670944
PLA2G1B,Phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,36707,0.0818105283035174,0.0421065116629171,-0.000718234555800223,0.164339291162835,0.0520577254395252
PLA2G1B,Phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,36707,0.0278171516870707,0.0425721379761561,-0.0556242387461953,0.111258542120337,0.513509167261527
PLA2G1B,Phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36707,-0.124528757516654,0.0433278358253636,-0.209451315734366,-0.0396061992989409,0.004062288249182
PLA2G1B,Phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,36707,0.00651443326578794,0.0421108268035683,-0.0760227872692059,0.0890516538007818,0.877063775368794
PLA2G1B,Phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36707,-0.184809120767243,0.0442351806561228,-0.271510074853243,-0.098108166681242,2.9733363719302e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,36707,-0.0424540437117186,0.0422191801733503,-0.125203636851485,0.0402955494280479,0.314655895009386
PLA2G1B,Phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,36707,-0.0734150656677502,0.0426338701533016,-0.156977451168221,0.010147319832721,0.085109653921392
PLA2G1B,Phospholipase A2,Diet and food preferences,X20663.Liking for fruit,36707,-0.0571819486071508,0.0449338170248674,-0.145252229975891,0.0308883327615892,0.203203088758931
PLA2G1B,Phospholipase A2,Diet and food preferences,X20664.Liking for garlic,36707,-0.159287930523822,0.0430502933160004,-0.243666505423183,-0.0749093556244614,0.000216991573130366
PLA2G1B,Phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,36707,-0.0958687825319568,0.0419526848013013,-0.178096044742507,-0.0136415203214062,0.0223289214164761
PLA2G1B,Phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,36707,-0.0335310155629213,0.0420716090598606,-0.115991369320248,0.0489293381944055,0.425475182398103
PLA2G1B,Phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,36707,-0.0510908229739362,0.0419118118882229,-0.133237974274853,0.0310563283269807,0.222876762959986
PLA2G1B,Phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,36707,0.0189741377206495,0.0425512954174753,-0.0644264012976021,0.102374676738901,0.655672659091263
PLA2G1B,Phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,36707,-0.00566162197787219,0.0423765214806351,-0.0887196040799169,0.0773963601241725,0.893719988810077
PLA2G1B,Phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,36707,-0.207369827159878,0.0421899846992251,-0.290062197170359,-0.124677457149397,9.04597903859618e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,36707,-0.0253130245208168,0.0421250508159147,-0.10787812412001,0.057252075078376,0.547922122705328
PLA2G1B,Phospholipase A2,Diet and food preferences,X20672.Liking for green olives,36707,-0.125316866017511,0.0423898910342656,-0.208401052444672,-0.0422326795903506,0.00312260974174639
PLA2G1B,Phospholipase A2,Diet and food preferences,X20673.Liking for haddock,36707,-0.0931913181326537,0.043038928442814,-0.177547617880569,-0.00883501838473838,0.0303953776330778
PLA2G1B,Phospholipase A2,Diet and food preferences,X20674.Liking for ham,36707,-0.0700881076841509,0.0427329859143234,-0.153844760076225,0.013668544707923,0.101014763547809
PLA2G1B,Phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,36707,-0.112627841608065,0.0430712096625045,-0.197047412546574,-0.0282082706695563,0.00894132989741091
PLA2G1B,Phospholipase A2,Diet and food preferences,X20676.Liking for herring,36707,-0.0757811427985977,0.042435616969357,-0.158954952058537,0.00739266646134211,0.0741705122676173
PLA2G1B,Phospholipase A2,Diet and food preferences,X20677.Liking for honey,36707,-0.0247297650558346,0.0424716313943308,-0.107974162588723,0.0585146324770537,0.560404080215567
PLA2G1B,Phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36707,-0.157912794235577,0.0422021344232942,-0.240628977705234,-0.0751966107659203,0.000183955274058125
PLA2G1B,Phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,36707,0.0737971392253007,0.0432821658483317,-0.0110359058374294,0.158630184288031,0.0882282698047768
PLA2G1B,Phospholipase A2,Diet and food preferences,X20680.Liking for jam,36707,0.123864638231868,0.0424742776994558,0.0406150539409349,0.207114222522802,0.00355264960681224
PLA2G1B,Phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,36707,-0.04919837766191,0.0426529408987962,-0.132798141823551,0.0344013864997307,0.248756472940814
PLA2G1B,Phospholipase A2,Diet and food preferences,X20682.Liking for lager,36707,-0.119010833678347,0.0422440674578701,-0.201809205895772,-0.0362124614609216,0.0048558629866581
PLA2G1B,Phospholipase A2,Diet and food preferences,X20683.Liking for lamb,36707,-0.127483040733338,0.0425346409962177,-0.210850937085924,-0.044115144380751,0.00273335821356697
PLA2G1B,Phospholipase A2,Diet and food preferences,X20684.Liking for lemons,36707,-0.129853890647841,0.042571286472975,-0.213293612134872,-0.0464141691608101,0.00229375588178411
PLA2G1B,Phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,36707,-0.0760787678169662,0.0427181638652092,-0.159806368992776,0.00764883335884377,0.0749586526653109
PLA2G1B,Phospholipase A2,Diet and food preferences,X20686.Liking for liver,36707,-0.102776557879888,0.0421268251478407,-0.185345135169656,-0.0202079805901205,0.0147210220313836
PLA2G1B,Phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,36707,-0.0800768371313714,0.0427599503830516,-0.163886339882152,0.00373266561940963,0.0611449273806603
PLA2G1B,Phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,36707,0.0651650261035961,0.0423100577886742,-0.0177626871622052,0.148092739369397,0.123556008820477
PLA2G1B,Phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,36707,-0.00997939421036197,0.0419782368367592,-0.0922567384104099,0.072297949989686,0.812098228727955
PLA2G1B,Phospholipase A2,Diet and food preferences,X20690.Liking for melon,36707,-0.012914069771412,0.0429526097607296,-0.097101184902442,0.0712730453596181,0.763682590581022
PLA2G1B,Phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,36707,0.0751028170401584,0.0426010693429411,-0.00839527887200604,0.158600912952323,0.0779495581201553
PLA2G1B,Phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,36707,-0.0369341927132129,0.0435542516434109,-0.122300525934298,0.0484321405078725,0.3964606389103
PLA2G1B,Phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,36707,0.0353020443993341,0.0432270746972348,-0.0494230220072461,0.120027110805914,0.414143849349062
PLA2G1B,Phospholipase A2,Diet and food preferences,X20695.Liking for oranges,36707,-0.0624507545607672,0.0432949831836127,-0.147308921600648,0.0224074124791136,0.149214753385872
PLA2G1B,Phospholipase A2,Diet and food preferences,X20696.Liking for pasta,36707,-0.00839042606601542,0.0432064398776453,-0.0930750482262002,0.0762941960941693,0.846028948158613
PLA2G1B,Phospholipase A2,Diet and food preferences,X20697.Liking for pears,36707,-0.0589548585534366,0.0425889183782644,-0.142429138574835,0.0245194214679616,0.166311809762205
PLA2G1B,Phospholipase A2,Diet and food preferences,X20698.Liking for pizza,36707,0.052638374361818,0.0427721676185148,-0.0311950741704711,0.136471822894107,0.218482487314632
PLA2G1B,Phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,36707,0.00851916227048531,0.042425914061356,-0.0746356292897724,0.091673953830743,0.84085929195789
PLA2G1B,Phospholipase A2,Diet and food preferences,X20700.Liking for plums,36707,-0.0418243809768137,0.0429351617943395,-0.125977298093719,0.0423285361400918,0.330021649431225
PLA2G1B,Phospholipase A2,Diet and food preferences,X20701.Liking for pollock,36707,-0.080872275014685,0.0424743034698522,-0.164121909815595,0.00237735978622532,0.056941909218197
PLA2G1B,Phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,36707,-0.0779817271036439,0.0425090526594979,-0.16129947031626,0.005336016108972,0.066620416830584
PLA2G1B,Phospholipase A2,Diet and food preferences,X20703.Liking for porridge,36707,0.0685655491793448,0.0427857263923864,-0.0152944745497327,0.152425572908422,0.109076742498114
PLA2G1B,Phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,36707,0.023019363309651,0.0424241472736366,-0.0601319653466767,0.106170691965979,0.587419830035266
PLA2G1B,Phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,36707,0.00446089960569672,0.0434085293051469,-0.0806198178323913,0.0895416170437847,0.918151624424154
PLA2G1B,Phospholipase A2,Diet and food preferences,X20706.Liking for prawns,36707,-0.105005060076455,0.0429059912991825,-0.189100803022853,-0.0209093171300573,0.0144130498407194
PLA2G1B,Phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,36707,-0.00671354229330261,0.0427221323197837,-0.0904489216400786,0.0770218370534734,0.875134992483207
PLA2G1B,Phospholipase A2,Diet and food preferences,X20708.Liking for red meat,36707,-0.131092297462915,0.0430146868235022,-0.215401083636979,-0.046783511288851,0.00231407151735731
PLA2G1B,Phospholipase A2,Diet and food preferences,X20709.Liking for red wine,36707,-0.274788741626919,0.0431594205987444,-0.359381206000459,-0.19019627725338,2.03483272483133e-10
PLA2G1B,Phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36707,0.126015267126422,0.0428857216251706,0.0419592527410876,0.210071281511756,0.00330845274742704
PLA2G1B,Phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,36707,-0.06981882946953,0.0437772591674009,-0.155622257437636,0.0159845984985758,0.11078139518534
PLA2G1B,Phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,36707,-0.132617008011484,0.0421375885725596,-0.215206681613701,-0.0500273344092671,0.00165418820611314
PLA2G1B,Phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,36707,-0.114371087725082,0.0425559967317587,-0.197780841319329,-0.0309613341308353,0.0072126862130154
PLA2G1B,Phospholipase A2,Diet and food preferences,X20714.Liking for salami,36707,-0.0980298463775743,0.0419147640639832,-0.180182783942981,-0.0158769088121673,0.0193704790465497
PLA2G1B,Phospholipase A2,Diet and food preferences,X20715.Liking for salmon,36707,-0.0488193211359791,0.0431742751329485,-0.133440900396558,0.0358022581246,0.258193724303945
PLA2G1B,Phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,36707,-0.0309036324798885,0.0424258991873838,-0.114058394887161,0.0522511299273837,0.466381062965742
PLA2G1B,Phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,36707,-0.0477262436735174,0.0418761697788333,-0.129803536440031,0.0343510490929958,0.254445285077302
PLA2G1B,Phospholipase A2,Diet and food preferences,X20718.Liking for sardines,36707,-0.0453065836369028,0.042415705237166,-0.128441365901748,0.0378281986279425,0.285482056950582
PLA2G1B,Phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),36707,-0.0496801992188064,0.0425276623458083,-0.133034417416591,0.0336740189789779,0.242766331561546
PLA2G1B,Phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,36707,-0.0484309700312647,0.0424851665886511,-0.131701896545021,0.0348399564824915,0.254340804685098
PLA2G1B,Phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36707,-0.11150857167729,0.0422168122932696,-0.194253523772098,-0.0287636195824811,0.00827396385191896
PLA2G1B,Phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,36707,0.0538463222114801,0.0423301921396484,-0.0291208543822308,0.136813498805191,0.203390192052092
PLA2G1B,Phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,36707,-0.125782943238847,0.0426344125114392,-0.209346391761268,-0.0422194947164264,0.0031840740561368
PLA2G1B,Phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,36707,-0.0527583725944576,0.0423663101445165,-0.13579634047771,0.0302795952887947,0.213060939699894
PLA2G1B,Phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,36707,-0.122663291990929,0.0427899852408098,-0.206531663062916,-0.0387949209189417,0.00415930379840903
PLA2G1B,Phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,36707,0.0962494650946936,0.0425784717066666,0.0127956605496271,0.17970326963976,0.0238154649007396
PLA2G1B,Phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,36707,-0.136479510617413,0.0426268862078821,-0.220028207584862,-0.0529308136499645,0.0013713590727598
PLA2G1B,Phospholipase A2,Diet and food preferences,X20728.Liking for spinach,36707,-0.0731890838375283,0.0430132510144042,-0.157495055825761,0.0111168881507038,0.0888786388643577
PLA2G1B,Phospholipase A2,Diet and food preferences,X20729.Liking for spirits,36707,-0.19735433933657,0.0422886447568096,-0.280240083059916,-0.114468595613223,3.10781301158841e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,36707,-0.0438397502150991,0.0440167003738198,-0.130112482947786,0.0424329825175877,0.319289655223066
PLA2G1B,Phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36707,0.0905466697199509,0.0429768787207628,0.00631198742725575,0.174781352012646,0.0351595795489564
PLA2G1B,Phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,36707,0.165381737665876,0.0424065855446673,0.0822648299983285,0.248498645333424,9.70075017072304e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,36707,-0.0197630150803027,0.0430892920275881,-0.104218027454375,0.0646919972937699,0.646495978632792
PLA2G1B,Phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,36707,0.137181584267076,0.0465546979161333,0.0459343763514548,0.228428792182697,0.00322125739288143
PLA2G1B,Phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,36707,-0.062898532142026,0.0434961171894796,-0.148150921833406,0.0223538575493541,0.148195612085099
PLA2G1B,Phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,36707,-0.0134429582427633,0.042086903234646,-0.0959332885826695,0.0690473720971428,0.749424219512254
PLA2G1B,Phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,36707,-0.0248910213683473,0.0423571538035184,-0.107911042823243,0.0581290000865487,0.556786164961634
PLA2G1B,Phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),36707,-0.100851646365609,0.0423462012303636,-0.183850200777121,-0.0178530919540959,0.0172606481962913
PLA2G1B,Phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,36707,-0.0657734583664843,0.0439158275822539,-0.151848480427702,0.0203015636947333,0.134245905963333
PLA2G1B,Phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,36707,-0.142739706282148,0.0425158405691973,-0.226070753797774,-0.0594086587665208,0.00079061702393238
PLA2G1B,Phospholipase A2,Diet and food preferences,X20741.Liking for watching television,36707,0.0753938691269931,0.0435454751602065,-0.00995526218701152,0.160743000440998,0.0834216701992018
PLA2G1B,Phospholipase A2,Diet and food preferences,X20742.Liking for whisky,36707,-0.144917671536901,0.0419738788756095,-0.227186474133096,-0.0626488689407064,0.000558116480038136
PLA2G1B,Phospholipase A2,Diet and food preferences,X20743.Liking for white bread,36707,0.0309468764932922,0.0417585983504732,-0.0508999762736353,0.11279372926022,0.458660407219414
PLA2G1B,Phospholipase A2,Diet and food preferences,X20744.Liking for white rice,36707,-0.0443951111006347,0.0429608101971875,-0.128598299087122,0.0398080768858527,0.301454032054585
PLA2G1B,Phospholipase A2,Diet and food preferences,X20745.Liking for white wine,36707,-0.0846228819531978,0.0422652812826194,-0.167462833267132,-0.00178293063926384,0.0452982022024916
PLA2G1B,Phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36707,0.091973289238602,0.0432650159026653,0.00717385806937802,0.176772720407826,0.0335490918510994
PLA2G1B,Phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,36707,0.0473337871309213,0.0421451713572668,-0.0352707487293216,0.129938322991164,0.261422827949202
PLA2G1B,Phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,36707,-0.0789527839451344,0.0435928987915861,-0.164394865576643,0.00648929768637428,0.070156428637158
PLA2G1B,Phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,36707,-0.00448203599023397,0.0428668237325588,-0.0885010105060492,0.0795369385255812,0.916729750149861
PLA2G1B,Phospholipase A2,Physical measures,X21001.Body mass index (BMI),52432,-0.138652689038148,0.0168526688311619,-0.171683919947225,-0.105621458129071,2.01101069871358e-16
PLA2G1B,Phospholipase A2,Physical measures,X21002.Weight,52465,-0.076917690246214,0.00815144862039375,-0.0928945295421858,-0.0609408509502423,4.21206868197527e-21
PLA2G1B,Phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36612,-0.022682242762737,0.00621631867514031,-0.034866227366012,-0.010498258159462,0.000265119642572405
PLA2G1B,Phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36477,0.00911544647094418,0.0466794224338227,-0.0823762214993484,0.100607114441237,0.845180656996158
PLA2G1B,Phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36479,0.0467515007360613,0.0475838733980788,-0.0465128911241732,0.140015892596296,0.325880191142345
PLA2G1B,Phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36480,-0.0453936166684484,0.0461410732421351,-0.135830120223033,0.0450428868861364,0.325243768380029
PLA2G1B,Phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,36451,0.0326758454399384,0.0426774932837628,-0.0509720413962367,0.116323732276114,0.443910100597809
PLA2G1B,Phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36451,-0.0560150252769746,0.046998718983938,-0.148132514485493,0.0361024639315439,0.233359453597643
PLA2G1B,Phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,36449,-0.00726793311125137,0.0463117406382771,-0.0980389447622745,0.0835030785397717,0.875300110939992
PLA2G1B,Phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,36414,0.0660793128920191,0.0463161120050499,-0.0247002666378788,0.156858892421917,0.153705622789753
PLA2G1B,Phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,36423,-0.0317685537447247,0.0509855750656081,-0.131700280873317,0.0681631733838672,0.533244184642365
PLA2G1B,Phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36486,0.00950929023665317,0.0465956464858757,-0.0818181768756632,0.10083675734897,0.838295399675382
PLA2G1B,Phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36482,0.0297415872096142,0.0461994981964367,-0.0608094292554018,0.12029260367463,0.519747025563861
PLA2G1B,Phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36484,-0.0261256184490813,0.0540733777169585,-0.13210943877432,0.0798582018761575,0.629001785688761
PLA2G1B,Phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36484,-0.0170901302363684,0.066995790978212,-0.148401880553664,0.114221620080927,0.798658237335369
PLA2G1B,Phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36484,-0.0164445409775387,0.0564674584970512,-0.127120759631759,0.0942316776766817,0.770889541427996
PLA2G1B,Phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36482,0.177669807264423,0.13575382047555,-0.0884076808676538,0.4437472953965,0.19065223185418
PLA2G1B,Phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36486,0.0952810359594915,0.057609063088779,-0.0176327276945153,0.208194799613498,0.098182676044669
PLA2G1B,Phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36483,0.0498662810935867,0.0523783737467172,-0.052795331449979,0.152527893637152,0.341106139303067
PLA2G1B,Phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36340,0.00630701112694013,0.0528802133547581,-0.0973382070483858,0.109952229302266,0.9050647250613
PLA2G1B,Phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36480,-0.00778439644950652,0.0478753249659768,-0.101620033382821,0.086051240483808,0.870839717686791
PLA2G1B,Phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36485,0.076333546941809,0.0810109368438486,-0.0824478892721342,0.235114983155752,0.346087265786634
PLA2G1B,Phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36486,-0.054070247264234,0.0467802175745452,-0.145759473710343,0.0376189791818746,0.247783373031226
PLA2G1B,Phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36485,-0.0569657567755215,0.0463837233555653,-0.14787785455243,0.0339463410013866,0.219430669189799
PLA2G1B,Phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52299,0.0379920795711904,0.0250581308163175,-0.0111218568287919,0.0871060159711728,0.129492803775203
PLA2G1B,Phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,49432,0.0136256206138127,0.00332835986695105,0.00710203527458866,0.0201492059530368,4.25970717031767e-05
PLA2G1B,Phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47728,-0.127168736692237,0.0287777324025048,-0.183573092201147,-0.070764381183328,9.970470801972e-06
PLA2G1B,Phospholipase A2,Physical activities,X22032.IPAQ activity group,48631,0.0111672335582029,0.027059553100363,-0.0418694905185086,0.0642039576349143,0.679837449460955
PLA2G1B,Phospholipase A2,Physical activities,X22033.Summed days activity,49042,-0.00414907138248431,0.00334496191341053,-0.0107051967327689,0.00240705396780031,0.214843858872264
PLA2G1B,Phospholipase A2,Physical activities,X22034.Summed minutes activity,48631,-0.00234433763966657,0.00337445621750766,-0.00895827182598157,0.00426959654664844,0.487232271029697
PLA2G1B,Phospholipase A2,Physical activities,X22037.MET minutes per week for walking,47901,-0.00570046815898686,0.00342814812085793,-0.0124196384758684,0.00101870215789468,0.0963603338983615
PLA2G1B,Phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,48631,-0.00803941209657583,0.00342513596630596,-0.0147526785905355,-0.00132614560261614,0.0189257744766076
PLA2G1B,Phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,48631,0.0160007439781945,0.0269299484142626,-0.0367819549137602,0.0687834428701491,0.5524106758387
PLA2G1B,Phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,47901,-0.00451210173851374,0.00339969371785445,-0.0111755014255084,0.00215129794848098,0.184455484830494
PLA2G1B,Phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,48695,-0.00428094032230154,0.00348598319418656,-0.0111134673829072,0.00255158673830412,0.219444880285528
PLA2G1B,Phospholipase A2,Working and living environment,X22501.Year ended full time education,34237,0.0213199188505313,0.0145216841500168,-0.0071425820835015,0.0497824197845642,0.142120993042088
PLA2G1B,Phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,34199,0.121289606220072,0.105334899884704,-0.0851667975539482,0.327746009994092,0.249589563219114
PLA2G1B,Phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51070,-0.0679303490106839,0.0784950171715907,-0.221780582667002,0.0859198846456338,0.386823200351253
PLA2G1B,Phospholipase A2,Physical measures,X23098.Weight,52017,-0.0748464174942786,0.00820733981877985,-0.0909328035390871,-0.0587600314494701,8.14227612258736e-20
PLA2G1B,Phospholipase A2,Physical measures,X23099.Body fat percentage,51986,-0.0391186203915956,0.00732847729797418,-0.053482435895625,-0.0247548048875662,9.4909400217755e-08
PLA2G1B,Phospholipase A2,Physical measures,X23100.Whole body fat mass,51944,-0.0636376997533012,0.00731386042665764,-0.0779728661895502,-0.0493025333170522,3.50398951277963e-18
PLA2G1B,Phospholipase A2,Physical measures,X23101.Whole body fat-free mass,52011,-0.0361142925735616,0.00709054598485011,-0.0500117627038678,-0.0222168224432553,3.54609819430787e-07
PLA2G1B,Phospholipase A2,Physical measures,X23102.Whole body water mass,52017,-0.034229068405649,0.00707420609174932,-0.0480945123454777,-0.0203636244658204,1.31605795301572e-06
PLA2G1B,Phospholipase A2,Physical measures,X23104.Body mass index (BMI),52017,-0.127735163188093,0.0166389185398693,-0.160347443526237,-0.0951228828499492,1.69354182204816e-14
PLA2G1B,Phospholipase A2,Physical measures,X23105.Basal metabolic rate,52017,-0.0421314733217293,0.00736791688207594,-0.0565725904105981,-0.0276903562328605,1.08946360696788e-08
PLA2G1B,Phospholipase A2,Physical measures,X23106.Impedance of whole body,52017,-0.0127266648594366,0.00580463173391604,-0.024103743057912,-0.00134958666096112,0.0283531060009748
PLA2G1B,Phospholipase A2,Physical measures,X23107.Impedance of leg (right),52017,-0.00528479315059609,0.00469676341156306,-0.0144904494372597,0.00392086313606751,0.260516280260444
PLA2G1B,Phospholipase A2,Physical measures,X23108.Impedance of leg (left),52017,-0.00564254170700052,0.00467795286712666,-0.0148113293265688,0.00352624591256773,0.227752985576611
PLA2G1B,Phospholipase A2,Physical measures,X23109.Impedance of arm (right),52017,-0.00710358067437542,0.00575259751095474,-0.0183786717958467,0.00417151044709587,0.216899654318342
PLA2G1B,Phospholipase A2,Physical measures,X23110.Impedance of arm (left),52017,-0.0115093174321025,0.00574341313016193,-0.0227664071672199,-0.000252227696985097,0.0450905566553913
PLA2G1B,Phospholipase A2,Physical measures,X23111.Leg fat percentage (right),52017,-0.0329384434726753,0.00747390898644142,-0.0475873050861005,-0.0182895818592502,1.0521755699221e-05
PLA2G1B,Phospholipase A2,Physical measures,X23112.Leg fat mass (right),52017,-0.0464869581548248,0.00804586426171077,-0.0622568521077779,-0.0307170642018717,7.66672430063413e-09
PLA2G1B,Phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),52016,-0.0432138919569081,0.00779400719588805,-0.0584901460608487,-0.0279376378529675,2.97970879578824e-08
PLA2G1B,Phospholipase A2,Physical measures,X23114.Leg predicted mass (right),52016,-0.0437508204450514,0.00785089052760724,-0.0591385658791616,-0.0283630750109412,2.53550589801938e-08
PLA2G1B,Phospholipase A2,Physical measures,X23115.Leg fat percentage (left),52016,-0.0420612796413475,0.00781375909756014,-0.0573762474725654,-0.0267463118101296,7.39684857596456e-08
PLA2G1B,Phospholipase A2,Physical measures,X23116.Leg fat mass (left),52016,-0.056151426444816,0.00850830520562427,-0.0728277046478395,-0.0394751482417924,4.21075150269096e-11
PLA2G1B,Phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),52015,-0.04966245080181,0.00847538322668179,-0.0662742019261063,-0.0330506996775137,4.70163176753956e-09
PLA2G1B,Phospholipase A2,Physical measures,X23118.Leg predicted mass (left),52015,-0.0501614393670258,0.00854234289331696,-0.0669044314379271,-0.0334184472961246,4.3613412964316e-09
PLA2G1B,Phospholipase A2,Physical measures,X23119.Arm fat percentage (right),52015,-0.0415516685133997,0.00823765558103388,-0.0576974734522261,-0.0254058635745733,4.59032416613765e-07
PLA2G1B,Phospholipase A2,Physical measures,X23120.Arm fat mass (right),52014,-0.0728726756262613,0.00898850791932601,-0.0904901511481403,-0.0552552001043824,5.42639851235984e-16
PLA2G1B,Phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),52013,-0.0366254230423951,0.00778599783382057,-0.0518859787966835,-0.0213648672881068,2.56554437443683e-06
PLA2G1B,Phospholipase A2,Physical measures,X23122.Arm predicted mass (right),52013,-0.0355112600570669,0.00782241914017688,-0.0508432015718136,-0.0201793185423202,5.66207454251159e-06
PLA2G1B,Phospholipase A2,Physical measures,X23123.Arm fat percentage (left),52011,-0.040162640112217,0.00775505054623989,-0.0553625391828472,-0.0249627410415868,2.25043526687476e-07
PLA2G1B,Phospholipase A2,Physical measures,X23124.Arm fat mass (left),52011,-0.0772105139133093,0.0086330146985337,-0.0941312227224354,-0.0602898051041833,4.03832866694674e-19
PLA2G1B,Phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),52007,-0.0280248210985557,0.0070931785207082,-0.0419274509991437,-0.0141221911979676,7.80685627486324e-05
PLA2G1B,Phospholipase A2,Physical measures,X23126.Arm predicted mass (left),52006,-0.02805573056122,0.00713289013161463,-0.0420361952191847,-0.0140752659032553,8.40323539202572e-05
PLA2G1B,Phospholipase A2,Physical measures,X23127.Trunk fat percentage,52004,-0.031052066050197,0.0062099296527381,-0.0432235281695637,-0.0188806039308303,5.7628054385216e-07
PLA2G1B,Phospholipase A2,Physical measures,X23128.Trunk fat mass,52004,-0.0571165526831809,0.00653730535761352,-0.0699296711841034,-0.0443034341822584,2.55094526676065e-18
PLA2G1B,Phospholipase A2,Physical measures,X23129.Trunk fat-free mass,52003,-0.0293507012185932,0.00615034686772742,-0.041405381079339,-0.0172960213578475,1.83321501756185e-06
PLA2G1B,Phospholipase A2,Physical measures,X23130.Trunk predicted mass,52001,-0.029023927541027,0.00614640784263437,-0.0410708869125904,-0.0169769681694636,2.34778886239806e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,42299,-0.035098948306917,0.0044718725074179,-0.0438638184214561,-0.0263340781923779,4.5097643223294e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42299,-0.0212456897698728,0.00437732344880777,-0.029825243729536,-0.0126661358102096,1.22588766483503e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42299,-0.0218578544365389,0.00440277163996017,-0.0304872868508609,-0.013228422022217,6.96828354801003e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,42299,-0.00956599650325638,0.00454617670353624,-0.0184765028421874,-0.00065549016432535,0.0353804933524346
PLA2G1B,Phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42299,-0.018229844449375,0.00436696048821502,-0.0267890870062765,-0.0096706018924736,3.00496397670507e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,42299,-0.0202093561872865,0.00434707042948237,-0.028729614229072,-0.0116890981455011,3.36726948402013e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,42299,-0.0603005621192151,0.00493242963647258,-0.0699681242067014,-0.0506330000317289,3.43092397551887e-34
PLA2G1B,Phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,42299,-0.0194523350707895,0.00461720294518696,-0.0285020528433559,-0.010402617298223,2.53599447128264e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,42299,-0.0158543092771934,0.00468743565360625,-0.0250416831582617,-0.00666693539612518,0.000720829538248538
PLA2G1B,Phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,42299,-0.0258544947583917,0.00434842916240447,-0.0343774159167045,-0.017331573600079,2.81960561554736e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,42299,-0.034283484980513,0.00451255783168637,-0.0431280983306183,-0.0254388716304077,3.21817388216557e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42299,-0.0561242727920565,0.00448092128563376,-0.0649068785118987,-0.0473416670722144,8.54044013540129e-36
PLA2G1B,Phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,42299,-0.0118662450536852,0.00459452535638524,-0.0208715147522003,-0.00286097535517015,0.0098135463301501
PLA2G1B,Phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,42299,-0.0196274786994229,0.00436236275783885,-0.028177709704787,-0.0110772476940587,6.87461249698487e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,42299,-0.071428489091161,0.00471184631328771,-0.0806637078652049,-0.0621932703171171,1.71897351329859e-51
PLA2G1B,Phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,42299,-0.0369711272435768,0.00449454444067654,-0.0457804343473028,-0.0281618201398508,2.11284914036825e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42299,-0.00834024433296757,0.00452065523205014,-0.0172007285877858,0.000520239921850709,0.0650708424475295
PLA2G1B,Phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42299,-0.0208502732351471,0.004346836448922,-0.0293700726750342,-0.0123304737952599,1.63036368756924e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42299,-0.0569077655113766,0.00493966151251696,-0.0665895020759098,-0.0472260289468434,1.43701159836535e-30
PLA2G1B,Phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,42299,-0.0298903837714302,0.00442076932808609,-0.0385550916544789,-0.0212256758883814,1.42245962653101e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42299,-0.0106379612462374,0.00457696075990189,-0.0196088043356451,-0.00166711815682969,0.0201271123700137
PLA2G1B,Phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,42299,-0.0177835532500202,0.00436803565297307,-0.0263449031298474,-0.00922220337019303,4.70155470313695e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,42299,-0.0676507161804559,0.00489688248546507,-0.0772486058519674,-0.0580528265089443,4.02315284066782e-43
PLA2G1B,Phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42299,-0.0408861517183443,0.00431788928874392,-0.0493492147242824,-0.0324230887124062,3.27994559816375e-21
PLA2G1B,Phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,42299,-0.0142078924476024,0.00459806989182211,-0.0232201094355737,-0.00519567545963107,0.00200578628700552
PLA2G1B,Phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,42299,-0.0211518739250237,0.00434786370241281,-0.0296736867817528,-0.0126300610682946,1.15794733250263e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,42299,-0.0689219585363634,0.00479232863185278,-0.0783149226547948,-0.0595289944179319,1.4707702806395e-46
PLA2G1B,Phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42299,-0.0627909983446405,0.00455024985170073,-0.0717094880539739,-0.053872508635307,4.98063451201319e-43
PLA2G1B,Phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,42299,-0.0106679317016893,0.00453664265600571,-0.0195597513074605,-0.00177611209591815,0.0187117914486173
PLA2G1B,Phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,42299,-0.00717212940307897,0.00437500607452848,-0.0157471413091548,0.00140288250299686,0.101165101599949
PLA2G1B,Phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,42299,-0.0639919668320282,0.00455264522939313,-0.0729151514816387,-0.0550687821824177,1.44354898912383e-44
PLA2G1B,Phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42299,-0.00452904115889716,0.0047580132602029,-0.0138547471488948,0.00479666483110053,0.34117639686904
PLA2G1B,Phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42299,0.00675551160537208,0.00450624382962095,-0.002076726300685,0.0155877495114291,0.133859137835759
PLA2G1B,Phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42299,-0.0357665480280715,0.00496209794625638,-0.045492260002734,-0.026040836053409,5.97737442767608e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,42290,-0.063616869350791,0.00448520123466517,-0.0724078637707348,-0.0548258749308473,2.41979725453087e-45
PLA2G1B,Phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42290,0.0110738864496638,0.00487038582545911,0.00152793023176389,0.0206198426675636,0.0229983301000987
PLA2G1B,Phospholipase A2,NMR metabolomics,X23436.Total Cholines,42290,-0.0601388302679744,0.00456503324323325,-0.0690862954247115,-0.0511913651112372,2.15615299411524e-39
PLA2G1B,Phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,42290,-0.0669359482959826,0.00457561931707337,-0.0759041621574464,-0.0579677344345188,4.24109598691946e-48
PLA2G1B,Phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,42290,-0.0384245867793653,0.00462381050691015,-0.0474872553729091,-0.0293619181858214,1.04503837479914e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,42299,-0.0104808992391595,0.00438975996232135,-0.0190848287653094,-0.00187696971300967,0.0169732245530657
PLA2G1B,Phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,42299,-0.0691985488525456,0.00468723879360513,-0.0783855368880117,-0.0600115608170795,6.01441307633178e-49
PLA2G1B,Phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42299,0.0264614930441734,0.00447878338429531,0.0176830776109546,0.0352399084773922,3.54101035072515e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,42290,-0.0373221100908689,0.00421046003782914,-0.045574611765014,-0.0290696084167238,8.65059193863069e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,42290,0.0151469536988313,0.0045785841649721,0.00617292873548596,0.0241209786621766,0.000941338796288905
PLA2G1B,Phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42290,-0.0272132120279808,0.00443411448782985,-0.0359040764241273,-0.0185223476318343,8.62859460026024e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42290,-0.0248100711632851,0.00436289443283243,-0.0333613442516366,-0.0162587980749335,1.32235739514796e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42290,-0.0277243418043565,0.00438332961640132,-0.036315667852503,-0.0191330157562099,2.61188701288251e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42290,-0.0268228861222641,0.00429422130014162,-0.0352395598705416,-0.0184062123739865,4.32792776728745e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,42290,-0.048238306501445,0.00414715765877919,-0.0563667355126522,-0.0401098774902378,3.98543836293725e-31
PLA2G1B,Phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,42290,-0.0141032553263934,0.00435773032625981,-0.0226444067658626,-0.00556210388692414,0.00121345490323291
PLA2G1B,Phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,42290,-0.0190645073710421,0.00440275771913115,-0.0276939125005392,-0.0104351022415451,1.50081949456425e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42290,-0.00955355861359395,0.00445184084700607,-0.0182791666737258,-0.00082795055346205,0.0318921518288528
PLA2G1B,Phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42290,0.0387163415556213,0.00435963255354002,0.0301714617506829,0.0472612213605598,7.46512671548011e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42290,0.0366914905800913,0.0044684043523242,0.0279334180495358,0.0454495631106467,2.38227099506316e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42290,0.00221246095553128,0.00469862763276342,-0.00699684920468502,0.0114217711157476,0.637738314573111
PLA2G1B,Phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42290,-0.0625455657116121,0.0040447147274136,-0.0704732065773427,-0.0546179248458814,1.73157301998397e-53
PLA2G1B,Phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42290,0.0410222717537119,0.00446469887233738,0.0322714619639306,0.0497730815434931,4.56406743579362e-20
PLA2G1B,Phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42290,0.0038316992227236,0.00436264729466344,-0.00471908947481674,0.0123824879202639,0.379798078117446
PLA2G1B,Phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42290,0.0169209499522242,0.00465444375251689,0.00779824019729109,0.0260436597071573,0.000278524094487327
PLA2G1B,Phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42290,0.0199042059530335,0.00439204846591709,0.011295790959836,0.028512620946231,5.89580087898051e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23460.Alanine,42296,-0.0122813443189977,0.00438416465500526,-0.020874307042808,-0.00368838159518737,0.00509691413567712
PLA2G1B,Phospholipase A2,NMR metabolomics,X23461.Glutamine,42252,-4.87172466124807e-05,0.00432244204103024,-0.00852070364703176,0.00842326915380679,0.991007582345562
PLA2G1B,Phospholipase A2,NMR metabolomics,X23462.Glycine,42285,0.0448814356572776,0.00520357674238409,0.0346824252422048,0.0550804460723505,7.10067760890774e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23463.Histidine,42282,0.013740978941599,0.00434553410874485,0.00522373208845906,0.0222582257947389,0.00156982091932442
PLA2G1B,Phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42289,-0.0166819010523432,0.00486697778653458,-0.026221177513951,-0.00714262459073547,0.000610803658693863
PLA2G1B,Phospholipase A2,NMR metabolomics,X23465.Isoleucine,42297,-0.0130578697091369,0.00469967488647033,-0.0222692324866187,-0.00384650693165501,0.00546912071021803
PLA2G1B,Phospholipase A2,NMR metabolomics,X23466.Leucine,42297,-0.0110081394752814,0.00483208904678334,-0.0204790340069767,-0.00153724494358605,0.0227340114781094
PLA2G1B,Phospholipase A2,NMR metabolomics,X23467.Valine,42289,-0.0208811567343997,0.00483230171022582,-0.0303524680864423,-0.0114098453823571,1.56304991686936e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23468.Phenylalanine,42291,0.011729167350306,0.00447590308866059,0.0029563972965312,0.0205019374040807,0.00878942445045638
PLA2G1B,Phospholipase A2,NMR metabolomics,X23469.Tyrosine,42285,-0.0321485131922379,0.00462135830973888,-0.0412063754793261,-0.0230906509051497,3.64659379377039e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23470.Glucose,42277,-0.0471419706687535,0.00421072279526857,-0.0553949873474799,-0.0388889539900271,5.72019709552893e-29
PLA2G1B,Phospholipase A2,NMR metabolomics,X23471.Lactate,42278,-0.00603450095394307,0.00444946987217111,-0.0147554619033985,0.00268645999551231,0.175048641642478
PLA2G1B,Phospholipase A2,NMR metabolomics,X23472.Pyruvate,42250,0.00073776458211328,0.00428278322977617,-0.00765649054824802,0.00913201971247458,0.863233417795403
PLA2G1B,Phospholipase A2,NMR metabolomics,X23473.Citrate,42296,0.0239944030055947,0.00442747003829353,0.0153165617305394,0.0326722442806501,6.07980875068979e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,42019,0.00236153574096481,0.00486500582536493,-0.00717387567675045,0.0118969471586801,0.627391531542199
PLA2G1B,Phospholipase A2,NMR metabolomics,X23475.Acetate,42287,-0.00745413478282691,0.0042187292800176,-0.0157228441716614,0.000814574606007575,0.0772647972115544
PLA2G1B,Phospholipase A2,NMR metabolomics,X23476.Acetoacetate,42298,-0.0152703123476643,0.00443673058174626,-0.023966304287887,-0.00657432040744164,0.000579595602747701
PLA2G1B,Phospholipase A2,NMR metabolomics,X23477.Acetone,42298,-0.0123127412312509,0.00440689238105808,-0.0209502502981247,-0.00367523216437706,0.0052137040962981
PLA2G1B,Phospholipase A2,NMR metabolomics,X23478.Creatinine,42036,0.149330653605633,0.00513331915506524,0.139269348061705,0.159391959149561,1.75353060907368e-180
PLA2G1B,Phospholipase A2,NMR metabolomics,X23479.Albumin,42297,-0.0147089238659184,0.00438367397725896,-0.023300924861346,-0.00611692287049084,0.000794692374906225
PLA2G1B,Phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,42299,0.0184693680582252,0.00456227721797758,0.00952730471098917,0.0274114314054613,5.18794582853771e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42299,-0.0167220325135068,0.00464461521551767,-0.0258254783359215,-0.00761858669109221,0.000318966567406944
PLA2G1B,Phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42299,-0.0173804561501538,0.00461660510507842,-0.0264290021561075,-0.00833191014420004,0.000167398948196417
PLA2G1B,Phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42299,-0.0155279417632748,0.00476949186148226,-0.02487614581178,-0.00617973771476955,0.00113395708873004
PLA2G1B,Phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42299,-0.0146302446791418,0.0046927212450791,-0.0238279783194968,-0.00543251103878673,0.00182678923081206
PLA2G1B,Phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42299,-0.0140459807435856,0.00469367093392162,-0.023245575774072,-0.00484638571309925,0.00277162777226044
PLA2G1B,Phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42299,-0.0157436382347594,0.00465988323732384,-0.0248770093799141,-0.00661026708960462,0.000730728032280136
PLA2G1B,Phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42299,-0.0188289445025092,0.00452579260002754,-0.0276994979985632,-0.00995839100645525,3.19679114539562e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42299,-0.0142722011945722,0.00484060640703859,-0.0237597897523679,-0.00478461263677659,0.00319929062209709
PLA2G1B,Phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42299,-0.0147388850050261,0.00480553867940614,-0.0241577408166621,-0.00532002919339007,0.0021659551689693
PLA2G1B,Phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42299,-0.0125421998011469,0.00480444998973524,-0.021958921781028,-0.00312547782126588,0.00904983236554149
PLA2G1B,Phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42299,-0.00819711310039156,0.00477690665128094,-0.0175598501369022,0.00116562393611907,0.0861869017285079
PLA2G1B,Phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42299,-0.00494519025956641,0.00477166255971458,-0.014297648876607,0.00440726835747416,0.300049580450601
PLA2G1B,Phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42299,-0.0109504393300714,0.0047642355925773,-0.0202883410915229,-0.00161253756861987,0.0215501967190371
PLA2G1B,Phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42299,-0.0173927666573098,0.00481720839767309,-0.026834495116749,-0.00795103819787052,0.0003066405090479
PLA2G1B,Phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42299,-0.0103624134101169,0.00477120910677866,-0.0197139832594031,-0.00101084356083074,0.029883081819886
PLA2G1B,Phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42299,-0.0107749838884921,0.00475804861134345,-0.0201007591667253,-0.00144920861025895,0.023553995684978
PLA2G1B,Phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42299,-0.00999475267450266,0.00485034932667613,-0.0195014373547879,-0.000488067994217434,0.0393576352574982
PLA2G1B,Phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42299,-0.00377096677974296,0.00479543053525687,-0.0131700106288464,0.00562807706936051,0.431666301547966
PLA2G1B,Phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42299,0.00130870353327252,0.00476110822566048,-0.00802306858902201,0.0106404756555671,0.783417402685217
PLA2G1B,Phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42299,-0.00812713620341023,0.00483754773968072,-0.0176087297731844,0.00135445736636399,0.0929778645988822
PLA2G1B,Phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42299,-0.0142102381752153,0.00469202962874244,-0.0234066162475505,-0.00501386010288011,0.00246154582680136
PLA2G1B,Phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42299,-0.00581655514404246,0.00449460753888809,-0.0146259859202631,0.00299287563217819,0.19564627917317
PLA2G1B,Phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42299,-0.0086900058282977,0.00450783201517276,-0.0175253565780363,0.000145344921440901,0.0539059759429612
PLA2G1B,Phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42299,-0.00701211162659928,0.00448260937831351,-0.0157980260080938,0.00177380275489521,0.117772022856328
PLA2G1B,Phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42299,-0.00151157739105534,0.00440060049803749,-0.0101367543672088,0.00711359958509814,0.73123254850687
PLA2G1B,Phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42299,0.000368155629393803,0.00438677030098093,-0.00822991416052882,0.00896622541931643,0.933118026164546
PLA2G1B,Phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42299,-0.00464746109681411,0.00445881179323347,-0.0133867322115517,0.00409181001792349,0.297286685506087
PLA2G1B,Phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42299,-0.0112333574968755,0.00463247462113499,-0.0203130077543001,-0.00215370723945093,0.0153248120857409
PLA2G1B,Phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42299,-0.000920517578569767,0.00464439874155134,-0.0100235391120104,0.00818250395487087,0.842891907832978
PLA2G1B,Phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42299,-0.00471037604515707,0.00464710063929145,-0.0138186932981683,0.00439794120785418,0.310783872207456
PLA2G1B,Phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42299,-0.0031595528250749,0.00455335071686544,-0.0120841202301312,0.00576501457998136,0.487759063717913
PLA2G1B,Phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42299,-0.000592937721324305,0.00459266930639757,-0.00959456956186354,0.00840869411921493,0.897276262829898
PLA2G1B,Phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42299,0.000543522032241374,0.00467554153074782,-0.00862053936802435,0.0097075834325071,0.907457754260247
PLA2G1B,Phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42299,-0.00217223523810982,0.00446494545790035,-0.0109235283355945,0.00657905785937487,0.626614253468781
PLA2G1B,Phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42299,-0.00683369439515222,0.00468707915242148,-0.0160203695338983,0.00235298074359388,0.144867407851571
PLA2G1B,Phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42299,-0.0187232551215758,0.00443737875678615,-0.0274205174848767,-0.0100259927582749,2.46485980570571e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42299,-0.0201367151674676,0.00446916745816269,-0.0288962833854665,-0.0113771469494687,6.67028445900978e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42299,-0.0146575516437576,0.00445731938785196,-0.0233938976439475,-0.00592120564356778,0.00101004269940744
PLA2G1B,Phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42299,-0.0210995006750667,0.004490629818478,-0.0299011351192835,-0.0122978662308498,2.64547772873507e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42299,-0.0233291007795142,0.00451962320547653,-0.0321875622622482,-0.0144706392967802,2.48094068129808e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42299,-0.0149775967651925,0.00445913013356487,-0.0237174918269796,-0.00623770170340533,0.000784779078461383
PLA2G1B,Phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42299,-0.0149466492344714,0.00455127846645265,-0.0238671550287186,-0.00602614344022424,0.00102581553706021
PLA2G1B,Phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,42299,-0.0212731859541609,0.00438894392076394,-0.0298755160388582,-0.0126708558694635,1.26720347095279e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,42299,-0.0323889690147581,0.00447880312684973,-0.0411674231433835,-0.0236105148861326,5.02603711938175e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,42299,-0.0259390186963903,0.00448040212713058,-0.0347206068655663,-0.0171574305272144,7.21690249929266e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,42299,-0.0323680219438491,0.00450030653168956,-0.0411886227459606,-0.0235474211417375,6.69633719221979e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42299,-0.0350898229387191,0.00450446596543169,-0.0439185762309652,-0.026261069646473,7.18063560051272e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,42299,-0.0237114268073261,0.00447386340538579,-0.0324801990818822,-0.0149426545327699,1.17605759115627e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,42299,-0.0251664402357979,0.00439340804523333,-0.0337775200044552,-0.0165553604671406,1.03618369794486e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42299,-0.00488071448359163,0.00435486186230999,-0.0134162437337192,0.00365481476653595,0.262413641056621
PLA2G1B,Phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,42299,-0.023742266736497,0.00436648686828003,-0.0323005809983258,-0.0151839524746681,5.49950773856278e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,42299,-0.0228518400664593,0.0043803096258348,-0.0314372469330955,-0.0142664331998231,1.84549740728309e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,42299,-0.022407298640147,0.00436875605493179,-0.0309700605078133,-0.0138445367724807,2.95279972794683e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42299,-0.0225321107918735,0.0043627645733716,-0.0310831293556818,-0.0139810922280651,2.44279648223869e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42299,-0.02158999407639,0.00440482677256985,-0.0302234545506269,-0.0129565336021531,9.62258430362866e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,42299,-0.0286694572648188,0.004340813009327,-0.0371774507630997,-0.0201614637665378,4.1321667947413e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42299,-0.0107976042259106,0.00440423321897542,-0.0194299013351024,-0.00216530711671877,0.0142329931056945
PLA2G1B,Phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42299,-0.0177548372009993,0.00437215447447391,-0.0263242599709682,-0.00918541443103048,4.91580472392246e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42299,-0.0169301618931783,0.00438845220670163,-0.0255315282183135,-0.00832879556804311,0.000114894483309413
PLA2G1B,Phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42299,-0.0168336956084106,0.00436614235101429,-0.0253913346163986,-0.00827605660042264,0.000116017534622321
PLA2G1B,Phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42299,-0.0176556573004068,0.00438345259422566,-0.0262472243850891,-0.00906409021572451,5.6605581787627e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42299,-0.0134871931562365,0.0043433051294011,-0.0220000712098627,-0.00497431510261038,0.00190484689446584
PLA2G1B,Phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42299,-0.0219600490964235,0.00437289821883903,-0.030530929605348,-0.013389168587499,5.18191422728973e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42299,-0.00846987092601762,0.0044074794142406,-0.0171085305779292,0.000168788725893943,0.0546637320732784
PLA2G1B,Phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,42299,-0.013113736969295,0.00434233982858603,-0.0216247230333236,-0.00460275090526636,0.00253265306285429
PLA2G1B,Phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,42299,-0.0100388501286363,0.00432723980408698,-0.0185202401446468,-0.00155746011262582,0.020359826967396
PLA2G1B,Phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,42299,-0.0129460436483786,0.00435476486307355,-0.0214813827800028,-0.00441070451675448,0.00295566094017188
PLA2G1B,Phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42299,-0.0151828751812338,0.00435747691693107,-0.0237235299384187,-0.00664222042404885,0.000494917946547396
PLA2G1B,Phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42299,-0.00614387611531063,0.0043507212158348,-0.0146712896983468,0.00238353746772557,0.157928165635153
PLA2G1B,Phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,42299,-0.0168914897442813,0.00442936902372574,-0.0255730530307838,-0.00820992645777885,0.000137601952781834
PLA2G1B,Phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42299,-0.0224366264707441,0.00505410644215665,-0.0323426750973711,-0.0125305778441171,9.09631621560301e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42299,-0.017971859521656,0.00507265645474875,-0.0279142661729635,-0.00802945287034843,0.000397085373843945
PLA2G1B,Phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42299,-0.0173152940360145,0.00504880668985077,-0.027210955148122,-0.00741963292390702,0.000606293824480941
PLA2G1B,Phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42299,-0.0148419089355749,0.00513094591247267,-0.0248985629240213,-0.00478525494712844,0.00382637223717462
PLA2G1B,Phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42299,-0.0164222562801214,0.00515594767020359,-0.0265279137137205,-0.00631659884652239,0.00145023541171534
PLA2G1B,Phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42299,-0.00851644622303038,0.00499295691557532,-0.018302641777558,0.00126974933149724,0.0880881256097331
PLA2G1B,Phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42299,-0.0210484694740786,0.00423078774639319,-0.0293408134570092,-0.0127561254911479,6.60147931040778e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42299,-0.0433210044390302,0.00508798523213668,-0.0532934554940181,-0.0333485533840423,1.84775663646014e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,42299,-0.0471287961854907,0.00504273075366267,-0.0570125484626695,-0.0372450439083119,1.05003990194089e-20
PLA2G1B,Phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,42299,-0.0524009105224745,0.0049906926057961,-0.0621826680298349,-0.0426191530151142,1.08446505466796e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,42299,-0.0372750844012748,0.0051243706093649,-0.04731885079563,-0.0272313180069196,3.677258966351e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42299,-0.03414188597592,0.00514355595628501,-0.0442232556502386,-0.0240605163016014,3.30386135237499e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42299,-0.045457090499232,0.00506084883502281,-0.0553763542158767,-0.0355378267825873,2.99866650972383e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,42299,-0.0372237946648995,0.00444336262181594,-0.0459327854036588,-0.0285148039261403,5.93345157132163e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42299,-0.0677206520943141,0.00463848399251135,-0.0768120807196363,-0.0586292234689919,6.45478033962093e-48
PLA2G1B,Phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42299,-0.0687784064765492,0.00455930731178183,-0.0777146488076415,-0.0598421641454568,5.19744884077783e-51
PLA2G1B,Phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42299,-0.0698326873348384,0.00447994925366807,-0.0786133878720278,-0.061051986797649,2.57708454951828e-54
PLA2G1B,Phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42299,-0.0641567106581722,0.00469679045703977,-0.0733624199539701,-0.0549510013623742,3.33956489220262e-42
PLA2G1B,Phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42299,-0.0621436021303687,0.00469255677989183,-0.0713410134189567,-0.0529461908417807,8.69451333323204e-40
PLA2G1B,Phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42299,-0.0701579606540582,0.00471141923201861,-0.0793923423488146,-0.0609235789593017,9.22936825225068e-50
PLA2G1B,Phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42299,-0.040168584570625,0.00455716263032413,-0.0491006233260603,-0.0312365458151897,1.34681241102926e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42299,-0.0497181327235248,0.00435654389661601,-0.0582569587608922,-0.0411793066861575,4.9614709809536e-30
PLA2G1B,Phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,42299,-0.0597082862488806,0.00434301152483826,-0.0682205888375636,-0.0511959836601976,1.00399395705396e-42
PLA2G1B,Phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,42299,-0.0644912129518136,0.00431446662778995,-0.0729475675422819,-0.0560348583613453,4.00458066569619e-50
PLA2G1B,Phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,42299,-0.0488138299230316,0.00433501031453376,-0.0573104501395177,-0.0403172097065454,2.76862502301026e-29
PLA2G1B,Phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42299,-0.0440206831424719,0.00436524767768888,-0.0525765685907421,-0.0354647976942017,7.84671038599985e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42299,-0.0572547303209945,0.0043131212725733,-0.0657084480152382,-0.0488010126267508,5.74080994260378e-40
PLA2G1B,Phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,42299,-0.0235697033508249,0.00491618483246681,-0.0332054256224599,-0.01393398107919,1.64953189883267e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41915,0.0244708116304974,0.00489636983393291,0.0148739267559889,0.0340676965050059,5.87411587370442e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41915,0.0218405312447405,0.00470058080208159,0.0126273928726606,0.0310536696168205,3.41101766842587e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41915,0.0201831877478802,0.00475991509512785,0.0108537541614297,0.0295126213343308,2.24786644223449e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41915,0.02005143181263,0.00470388951154166,0.0108318083700084,0.0292710552552517,2.03331091229878e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41915,-0.023649928750948,0.00476006356032753,-0.03297965332919,-0.0143202041727061,6.83435874661563e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42225,0.0178745101709206,0.00482008140152489,0.00842715062393181,0.0273218697179094,0.000209448694609703
PLA2G1B,Phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42225,0.0272676840806686,0.00486482052037185,0.0177326358607398,0.0368027323005974,2.12204304849368e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42225,0.0249595131560092,0.00483505412145889,0.0154828070779498,0.0344362192340686,2.47500167207969e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42225,0.0309062600745175,0.00487976131920592,0.0213419278888739,0.0404705922601611,2.47092104956394e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42225,-0.02966965703446,0.00484920191178689,-0.0391740927815624,-0.0201652212873577,9.7070994289177e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42299,0.00634650280615862,0.00505015536616246,-0.00355180171151981,0.016244807323837,0.208885684218592
PLA2G1B,Phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42299,0.031249743253551,0.00471595762675793,0.0220064663051054,0.0404930202019965,3.56868828094971e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42299,0.0310333886909681,0.00479110961537614,0.0216428138448308,0.0404239635371053,9.65752794410511e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42299,0.0242361034221838,0.00478883581780611,0.0148499852192838,0.0336222216250837,4.22558834025997e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42299,-0.0288424402054858,0.00481134008863612,-0.0382726667792126,-0.019412213631759,2.0901168038775e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42299,0.00371234472857533,0.00463149793573406,-0.00536539122546343,0.0127900806826141,0.422831266267985
PLA2G1B,Phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42299,0.0095052046573681,0.0047907190545395,0.000115395310470678,0.0188950140042655,0.0472660365461904
PLA2G1B,Phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42299,0.00926763968565961,0.00482168893912374,-0.000182870635022927,0.0187181500063421,0.054617249132932
PLA2G1B,Phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42299,0.00961437999149284,0.00468683564201163,0.000428182133150037,0.0188005778498356,0.0402510242358942
PLA2G1B,Phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42299,-0.00875545569222714,0.00475154945112994,-0.0180684926164418,0.000557581231987549,0.0654013203165587
PLA2G1B,Phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42299,0.00285557758841603,0.00466721298631519,-0.00629215986476173,0.0120033150415938,0.540655194293845
PLA2G1B,Phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42299,0.00777482089747508,0.00450671581603207,-0.00105834210194777,0.0166079838968979,0.0845205944634489
PLA2G1B,Phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42299,0.0117221199649126,0.00444047088072931,0.00301879703868318,0.0204254428911421,0.00830398523600939
PLA2G1B,Phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42299,0.00126772190398266,0.00470683881169689,-0.00795768216694326,0.0104931259749086,0.78767506261111
PLA2G1B,Phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42299,-0.00639573970885623,0.00455200979019933,-0.0153176788976469,0.00252619947993445,0.160033112919061
PLA2G1B,Phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42299,0.0395360867365742,0.00441614398519644,0.0308804445255891,0.0481917289475592,3.91254880756353e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42299,-0.0113975450236182,0.00465536461846444,-0.0205220596758085,-0.00227303037142792,0.0143672380536404
PLA2G1B,Phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42299,-0.016414715318941,0.00471839775799902,-0.0256627749246191,-0.00716665571326291,0.000505088158522723
PLA2G1B,Phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42299,0.0180632926618263,0.004108797834689,0.0100100489058358,0.0261165364178167,1.10967708548809e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42299,0.00394075157853302,0.00459649731445489,-0.00506838315779856,0.0129498863148646,0.391273139636729
PLA2G1B,Phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42299,0.0453863081345638,0.00430260737535115,0.0369531976788756,0.0538194185902521,6.48412264737264e-26
PLA2G1B,Phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42299,-0.0227130018851836,0.00452232392203976,-0.0315767567723816,-0.0138492469979857,5.16669407146163e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42299,-0.0355892286661346,0.00445312542318168,-0.0443173544955707,-0.0268611028366985,1.43365593850447e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42299,0.0188196370112836,0.00415452536766016,0.0106767672906697,0.0269625067318975,5.9506553722217e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42299,0.00766857779697216,0.00455811106189933,-0.00126531988435052,0.0166024754782948,0.0925135918843481
PLA2G1B,Phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42299,0.0152173012774731,0.00442595353944834,0.00654243234015433,0.0238921702147918,0.000587342421411032
PLA2G1B,Phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42299,-0.00167671159865713,0.00450906879683723,-0.0105144864404581,0.00716106324314383,0.710007913183066
PLA2G1B,Phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42299,-0.00127473717663664,0.00431525977702612,-0.00973264633960783,0.00718317198633455,0.767691139634555
PLA2G1B,Phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42299,-0.0047174890165775,0.00482841529516001,-0.0141811829950911,0.00474620496193612,0.32857335564413
PLA2G1B,Phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42299,-0.00358487694463706,0.00443958122392133,-0.0122864561435229,0.00511670225424875,0.419403506979332
PLA2G1B,Phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42299,0.0110734222146042,0.00454803562654085,0.00215927238658414,0.0199875720426243,0.0149139225735589
PLA2G1B,Phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42299,-0.00197696313271216,0.00449415335749222,-0.0107855037133969,0.00683157744797259,0.660018881706477
PLA2G1B,Phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42299,-0.00833296735094448,0.00454220342174885,-0.0172356860575722,0.000569751355683268,0.0665918448174158
PLA2G1B,Phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42299,0.0100412092047652,0.00466643474999121,0.000894997094782385,0.0191874213147479,0.0314309558565697
PLA2G1B,Phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42299,-0.00536649305606265,0.00442723318703908,-0.0140438701026592,0.00331088399053393,0.225473940537567
PLA2G1B,Phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42299,0.0208483267961852,0.00451381252107111,0.0120012542548859,0.0296953993374846,3.89508334107401e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42299,-0.00705874469054579,0.00440782111760968,-0.0156980740810608,0.00158058469996918,0.109308399689729
PLA2G1B,Phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42299,-0.0187807297890401,0.0044756584950064,-0.0275530204392527,-0.0100084391388276,2.73149027775773e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42299,0.0148734943759864,0.00443778562761067,0.00617543454586948,0.0235715542061033,0.000805756376405977
PLA2G1B,Phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42299,-0.00853561726258624,0.00451687694889339,-0.0173886960824173,0.000317461557244806,0.0588169699296742
PLA2G1B,Phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42286,-0.0176380751158831,0.00481674056221357,-0.0270788866178216,-0.00819726361394446,0.000251365568246333
PLA2G1B,Phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42286,0.022414359111928,0.00417984305615958,0.0142218667218552,0.0306068515020007,8.34171809595449e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42286,0.00332437502216891,0.00389886703750159,-0.00431740437133421,0.010966154415672,0.393867487322
PLA2G1B,Phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42286,0.0284246273154997,0.00498590991820327,0.0186522438758213,0.0381970107551781,1.21572288398892e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42286,-0.00316369546564178,0.00470470448766826,-0.0123849162614716,0.006057525330188,0.501306322851489
PLA2G1B,Phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42299,-0.0235511177039123,0.00443264597300694,-0.0322391038110059,-0.0148631315968187,1.09459960382276e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42299,0.00941253517668796,0.0046886696996,0.000222742565471968,0.018602327787904,0.0447153556862019
PLA2G1B,Phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42299,0.0162476397070133,0.00451138739177236,0.00740532041913945,0.0250899589948871,0.000317538403792516
PLA2G1B,Phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42299,-0.0221037618472075,0.00448092781993067,-0.0308863803742716,-0.0133211433201434,8.1987751288396e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42299,0.00693575138135716,0.00450955310381867,-0.00190297270212743,0.0157744754648417,0.124068527598968
PLA2G1B,Phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42299,0.0037628878043696,0.00480879732433372,-0.00566235495132449,0.0131881305600637,0.433933834750478
PLA2G1B,Phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42299,-0.00387892612846077,0.00480303896517095,-0.0132928825001958,0.00553503024327428,0.41933588496984
PLA2G1B,Phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42299,0.00834059801449472,0.00456634377522171,-0.000609435784939822,0.0172906318139293,0.0677910933757188
PLA2G1B,Phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42299,-0.0545637409268947,0.00497453258512515,-0.06431382479374,-0.0448136570600495,7.06466069445294e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42299,0.00339998951885755,0.00473543863701019,-0.00588147020968241,0.0126814492473975,0.472776747152487
PLA2G1B,Phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42299,-0.0459260731496832,0.00438259188089688,-0.0545159532362411,-0.0373361930631253,1.34522053011864e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42299,0.0239647232108395,0.00435608255523161,0.0154268014025855,0.0325026450190934,3.83461801101575e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42299,0.0242950030709947,0.00429618243815331,0.0158744854922142,0.0327155206497752,1.58940802810115e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42299,-0.00307039099998774,0.00465594991291553,-0.0121960528293022,0.0060552708293267,0.509614505499862
PLA2G1B,Phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42299,0.00949409845528905,0.00492733459662079,-0.00016347735408769,0.0191516742646658,0.0540224317827717
PLA2G1B,Phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52216,0.00703676510741521,0.00365903015355341,-0.000134933993549478,0.0142084642083799,0.0544766122489484
PLA2G1B,Phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52216,0.0054547333428449,0.00355374227205994,-0.00151060151039258,0.0124200681960824,0.124815268764698
PLA2G1B,Phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50653,0.000249108540257812,0.00340229563314953,-0.00641939090071527,0.0069176079812309,0.941633480332995
PLA2G1B,Phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50653,0.00350554536442491,0.00370610721709802,-0.0037584247810872,0.010769515509937,0.34421841509293
PLA2G1B,Phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50653,0.0048091545727637,0.00367034467248435,-0.00238472098530562,0.012003030130833,0.190117048135301
PLA2G1B,Phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50653,-0.00250358638172668,0.00337415964314049,-0.00911693928228205,0.00410976651882869,0.45810243347179
PLA2G1B,Phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,52216,-0.0823891594519248,0.0536661587568782,-0.187574830615406,0.0227965117115565,0.124744112832641
PLA2G1B,Phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,52216,-0.000819053402226718,0.00319365331170495,-0.00707861389316843,0.00544050708871499,0.797595703507769
PLA2G1B,Phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,52216,-0.000789046092595197,0.0031876041528759,-0.00703675023223196,0.00545865804704156,0.804495753402119
PLA2G1B,Phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,52216,-0.000226548661076667,0.00323274955950483,-0.00656273779770614,0.00610964047555281,0.94413117641696
PLA2G1B,Phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,52216,-0.026021955651402,0.0373913993329344,-0.0993090983439534,0.0472651870411495,0.486476852356838
PLA2G1B,Phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,52216,-0.0241377406261134,0.0362992000528127,-0.0952841727296263,0.0470086914773994,0.506078614382538
PLA2G1B,Phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52216,0.00774042168866687,0.00367239548164032,0.000542526544651844,0.0149383168326819,0.0350647773196017
PLA2G1B,Phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52216,0.00710436932467766,0.00367208426233637,-9.291582950162e-05,0.0143016544788569,0.0530394526142668
PLA2G1B,Phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52216,0.00742435173115389,0.00362897112930021,0.00031156831772548,0.0145371351445823,0.0407816103883243
PLA2G1B,Phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52179,0.00416207441731625,0.00354870059774776,-0.00279337875426936,0.0111175275889019,0.240869967947761
PLA2G1B,Phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,52216,-0.00428255135303224,0.00318978247995519,-0.0105345250137444,0.00196942230767994,0.179419574856749
PLA2G1B,Phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,52216,-0.00431264212453215,0.00319003050129502,-0.0105651019070704,0.00193981765800609,0.176416253953263
PLA2G1B,Phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,52216,-0.00427875411978252,0.00318988990225816,-0.0105309383282085,0.00197343008864348,0.179820220261471
PLA2G1B,Phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52216,-0.00428441500436039,0.00318983431653275,-0.0105364902647646,0.00196766025604379,0.179237427479605
PLA2G1B,Phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52216,-0.00428766966016745,0.00318989824538537,-0.0105398702211228,0.00196453090078788,0.178916048244621
PLA2G1B,Phospholipase A2,Health and medical history,X2405.Number of children fathered,52214,-0.0564751124751375,0.0283655865374,-0.112071662088441,-0.000878562861833555,0.0464953773818508
PLA2G1B,Phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49682,-0.00744725765796197,0.00379057520788659,-0.0148767850654197,-1.77302505042559e-05,0.0494646943289935
PLA2G1B,Phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49682,0.00864397368244577,0.00340676088175514,0.0019667223542057,0.0153212250106858,0.0111782673068716
PLA2G1B,Phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",49682,-0.00240726769027462,0.0034376286821156,-0.00914501990722119,0.00433048452667195,0.483766530154804
PLA2G1B,Phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49682,-0.00801318594462819,0.00355963390669103,-0.0149900684017426,-0.00103630348751377,0.0243877878103336
PLA2G1B,Phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49682,0.00828099738031652,0.00344051574842716,0.00153758651339929,0.0150244082472338,0.0160968602778005
PLA2G1B,Phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",49682,-0.0017300620382661,0.00345671764109051,-0.00850522861480351,0.00504510453827131,0.616733400661316
PLA2G1B,Phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52300,-0.0084192090545314,0.00363453707942881,-0.0155429017302119,-0.00129551637885093,0.0205424119101491
PLA2G1B,Phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52300,-0.0122484802038444,0.00339945394743806,-0.018911409940823,-0.00558555046686582,0.000315120977448242
PLA2G1B,Phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52300,0.00109655014023895,0.00321063039573059,-0.00519628543539302,0.00738938571587091,0.732702133430596
PLA2G1B,Phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,35593,-0.0117277012100654,0.00604704029546984,-0.0235799001891863,0.000124497769055459,0.0524913842330933
PLA2G1B,Phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",37120,0.00381303590148096,0.0595966075763968,-0.112996314948257,0.120622386751219,0.948987052626645
PLA2G1B,Phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,37119,-0.00585307034470949,0.0676078294454888,-0.138364416057867,0.126658275368449,0.931012284580325
PLA2G1B,Phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,37119,-0.0743309498017292,0.0635667274385523,-0.198921735581292,0.0502598359778332,0.242300456941052
PLA2G1B,Phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",37108,-0.0223140499509479,0.0636304283926507,-0.147029689600543,0.102401589698648,0.725835567213132
PLA2G1B,Phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,37125,0.030291760591479,0.0536206552844213,-0.0748047237659867,0.135388244948945,0.572138228965571
PLA2G1B,Phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,37142,-0.111251660440987,0.0618253620449522,-0.232429370049093,0.00992604916711949,0.0719827840397813
PLA2G1B,Phospholipase A2,Mental health,X28741.Difficulty learning a new task,37094,-0.00565497680306986,0.0734728982769165,-0.149661857425826,0.138351903819686,0.938651737983668
PLA2G1B,Phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,36663,-0.0548511500654864,0.0673825234192048,-0.186920895967128,0.077218595836155,0.415653899917885
PLA2G1B,Phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,37088,0.00863760543348861,0.0592385313777226,-0.107469916066848,0.124745126933825,0.884074376304488
PLA2G1B,Phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,37148,-0.0396498004398749,0.0798028728072863,-0.196063431142156,0.116763830262406,0.619309885241556
PLA2G1B,Phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34984,-0.119515387436617,0.0520335965823816,-0.221501236738085,-0.0175295381351495,0.0216573335639784
PLA2G1B,Phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,35587,-0.0118097634858678,0.00635266286229665,-0.0242609826959692,0.000641455724233651,0.0630655085145019
PLA2G1B,Phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,36167,-0.0104006262421837,0.0119386314578263,-0.0338003438995233,0.0129990914151558,0.38368674930938
PLA2G1B,Phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,36167,-0.00635568606985192,0.0135078876258433,-0.0328311458165048,0.020119773676801,0.637999500913784
PLA2G1B,Phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,36167,0.0320832592921397,0.0448928492607022,-0.0559067252588367,0.120073243843116,0.474839338648124
PLA2G1B,Phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,36167,0.00728186712748708,0.0442724646714127,-0.0794921636284818,0.094055897883456,0.869358889744215
PLA2G1B,Phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,36167,0.00402044277767747,0.0550677907422708,-0.103912427077173,0.111953312632528,0.941800907797529
PLA2G1B,Phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,36167,-0.0167369711006537,0.0492776241240029,-0.113321114383699,0.0798471721823921,0.73413220431378
PLA2G1B,Phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,36167,0.0121467210518055,0.0202730277214203,-0.0275884132821782,0.0518818553857892,0.549086309428543
PLA2G1B,Phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,36167,-0.0114774124585215,0.0381071715768069,-0.0861674687490631,0.06321264383202,0.763279622213408
PLA2G1B,Phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,36119,0.0425381386102573,0.0642735465890253,-0.0834380127042323,0.168514289924747,0.508100691200864
PLA2G1B,Phospholipase A2,Mental health,X29003.Recent feelings of depression,36120,0.0343546793980565,0.0639574067685296,-0.0910018378682614,0.159711196664374,0.591180351951197
PLA2G1B,Phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",36124,0.0604588058115829,0.0501863809536595,-0.0379065008575897,0.158824112480756,0.228362634373422
PLA2G1B,Phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,36126,-0.0589200028379476,0.0493752897392003,-0.15569557072678,0.037855565050885,0.232785804780098
PLA2G1B,Phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,36132,-0.0105498748569418,0.0784304651114513,-0.164273586475386,0.143173836761503,0.893000953412186
PLA2G1B,Phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,36108,0.00210370174747863,0.0703683860210655,-0.13581833485381,0.140025738348767,0.976151148022264
PLA2G1B,Phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,36128,0.0886265662102525,0.0666443011928381,-0.0419962641277101,0.219249396548215,0.183609768674348
PLA2G1B,Phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,36126,0.200226244857567,0.11333148376184,-0.0219034633156386,0.422355953030773,0.0773138273652538
PLA2G1B,Phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,36103,0.0310507213617694,0.124922387589622,-0.21379715831389,0.275898601037429,0.803707878862132
PLA2G1B,Phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,36063,0.0214772499478355,0.0239771296666192,-0.0255179241987382,0.0684724240944092,0.370421070235035
PLA2G1B,Phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36063,0.0459739191148204,0.0439816974256405,-0.040230207839435,0.132178046069076,0.295919760016122
PLA2G1B,Phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36063,0.012355412334738,0.0265208543225014,-0.0396254621373647,0.0643362868068407,0.641318320814218
PLA2G1B,Phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36063,-0.0101135437369757,0.0808619697153305,-0.168603004379024,0.148375916905072,0.900470158919361
PLA2G1B,Phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36063,0.0337480265357374,0.0525656622842516,-0.0692806715413956,0.136776724612871,0.520882139341795
PLA2G1B,Phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36063,-0.0211153283221281,0.0603139645739705,-0.13933069888711,0.097100042242854,0.726280879864591
PLA2G1B,Phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36063,-0.119432533736157,0.0622365843781174,-0.241416239117267,0.00255117164495322,0.0550213558027857
PLA2G1B,Phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36063,0.0602673846351156,0.0731544428614509,-0.0831153233733282,0.203650092643559,0.410058135370128
PLA2G1B,Phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36063,-0.0417673194185156,0.0521545330407472,-0.14399020417838,0.0604555653413489,0.42325106947009
PLA2G1B,Phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36063,0.0176647025825945,0.022549588282612,-0.0265324904513251,0.061861895616514,0.433433903677787
PLA2G1B,Phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36063,0.0783082427388612,0.0365887398070976,0.00659431271694985,0.150022172760773,0.0323686731833761
PLA2G1B,Phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36063,-0.0401595884693326,0.0577234603858655,-0.153297570825629,0.0729783938869638,0.486623445874142
PLA2G1B,Phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36063,-0.0269104551878414,0.0708489377156244,-0.165774373110465,0.111953462734782,0.70408343411258
PLA2G1B,Phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36063,0.0669184842112002,0.0424618352530718,-0.0163067128848206,0.150143681307221,0.115075614690774
PLA2G1B,Phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36063,0.0582159634723527,0.0655172178407907,-0.0701977834955971,0.186629710440303,0.374268362013689
PLA2G1B,Phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36063,-0.0459760606324831,0.0650258194957301,-0.173426666844114,0.0814745455791478,0.479561734982216
PLA2G1B,Phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36063,-0.0320076574896346,0.0367670152867709,-0.104071007451706,0.0400556924724364,0.38402594179912
PLA2G1B,Phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36063,-0.00982216599178197,0.0348307126657083,-0.0780903628165702,0.0584460308330062,0.777953420531828
PLA2G1B,Phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36063,0.0386554572366498,0.0522367037409951,-0.0637284820957006,0.141039396569,0.459319828252601
PLA2G1B,Phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,36007,0.0826460980960437,0.0624651009136503,-0.0397854996947109,0.205077695886798,0.185850839147586
PLA2G1B,Phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,36013,0.0762472782706815,0.0660840950236859,-0.0532775479757428,0.205772104517106,0.248622797859558
PLA2G1B,Phospholipase A2,Mental health,X29060.Recent worrying too much about different things,36011,-0.00542323768871557,0.0585657803467142,-0.120212167168275,0.109365691790844,0.92622321757653
PLA2G1B,Phospholipase A2,Mental health,X29061.Recent trouble relaxing,36008,0.0488105376786748,0.0624115256135669,-0.0735160525239163,0.171137127881266,0.434195088368691
PLA2G1B,Phospholipase A2,Mental health,X29062.Recent restlessness,36016,0.00278321581653146,0.0859503450080932,-0.165679460399331,0.171245892032394,0.974168550699741
PLA2G1B,Phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,36004,0.0383447519101865,0.0600824611979603,-0.0794168720378157,0.156106375858189,0.523361884591211
PLA2G1B,Phospholipase A2,Mental health,X29064.Recent feelings of foreboding,36007,-0.0233576034143118,0.0743433620751083,-0.169070593081524,0.122355386252901,0.753389035970601
PLA2G1B,Phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36063,0.00887486458846589,0.0286477426850236,-0.0472747110741804,0.0650244402511122,0.75672717221552
PLA2G1B,Phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36063,0.0484848548629041,0.0435580770689732,-0.0368889761922834,0.133858685918091,0.265697792289058
PLA2G1B,Phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36063,0.116197137024143,0.0599031687758975,-0.00121307377661568,0.233607347824903,0.0524477801014568
PLA2G1B,Phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36063,-0.00534678428808571,0.0594048677863862,-0.121780325149403,0.111086756573231,0.928284999200035
PLA2G1B,Phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36063,0.0353093065963668,0.0368857842914401,-0.0369868306148559,0.107605443807589,0.338466763988627
PLA2G1B,Phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36063,0.0747035302808543,0.046547353402532,-0.0165292823881085,0.165936342949817,0.108559625317843
PLA2G1B,Phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36063,-0.0438624472478926,0.0442934059494125,-0.130677522908741,0.0429526284129559,0.322074092500714
PLA2G1B,Phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36063,-0.00911262226382955,0.0441162476089094,-0.095580467577292,0.0773552230496329,0.836359665072439
PLA2G1B,Phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36063,-0.0489390524597401,0.0558449896408307,-0.158395232155768,0.0605171272362881,0.380874850037904
PLA2G1B,Phospholipase A2,Mental health,X29076.Felt loved as a child,35975,0.0300381962564906,0.0502351703955206,-0.0684227377187297,0.128499130231711,0.549890653049085
PLA2G1B,Phospholipase A2,Mental health,X29077.Physically abused by family as a child,35987,-0.112433807989889,0.0648355883309625,-0.239511561118575,0.0146439451387979,0.0829354712931466
PLA2G1B,Phospholipase A2,Mental health,X29078.Felt hated by family member as a child,35980,-0.0413878897019012,0.0732892526555258,-0.185034824906732,0.102259045502929,0.572281557530424
PLA2G1B,Phospholipase A2,Mental health,X29079.Sexually molested as a child,35963,-0.00806313170212307,0.108237711087938,-0.220209045434481,0.204082782030235,0.940618812984342
PLA2G1B,Phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,35974,-0.0646367183301886,0.0758375758040059,-0.21327836690604,0.0840049302456628,0.394072718312426
PLA2G1B,Phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35984,-0.0771838400973112,0.112387164845534,-0.297462683194559,0.143095002999936,0.492250890355296
PLA2G1B,Phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35958,-0.0166956626931442,0.0954868608397894,-0.203849909939132,0.170458584552843,0.861204079193172
PLA2G1B,Phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35996,0.0702741068938486,0.108553022888064,-0.142489817966757,0.283038031754454,0.51741178884985
PLA2G1B,Phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35988,-0.154770345287672,0.338319525083219,-0.817876614450781,0.508335923875437,0.647348175436784
PLA2G1B,Phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35981,-0.0261616121726044,0.202729876200729,-0.423512169526034,0.371188945180825,0.897324249514265
PLA2G1B,Phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,36002,-0.0868048458823256,0.117019003459743,-0.316162092663421,0.14255240089877,0.458231287145131
PLA2G1B,Phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,35993,-0.000750900767751864,0.0564487460796636,-0.111390443083892,0.109888641548389,0.98938693527478
PLA2G1B,Phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,35992,-0.108679130241924,0.0570163822748947,-0.220431239500718,0.0030729790168694,0.0566755191232794
PLA2G1B,Phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,36003,-0.0844545118729078,0.0837172685854387,-0.248540358300368,0.079631334554552,0.313100492102379
PLA2G1B,Phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35996,-0.0657658047388685,0.0699078957307204,-0.20278528037108,0.0712536708933435,0.346864070797351
PLA2G1B,Phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35989,-0.41203271857315,0.0473837809328041,-0.504904929201446,-0.319160507944854,4.20059676543826e-18
PLA2G1B,Phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35383,-0.240378494219369,0.0495107991822335,-0.337419660616547,-0.143337327822191,1.23038139182642e-06
PLA2G1B,Phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35404,-0.298498915273695,0.0495569290450585,-0.39563049620201,-0.201367334345381,1.79750391843679e-09
PLA2G1B,Phospholipase A2,Mental health,X29104.Ever used cannabis,35983,0.0297671577757314,0.0630995643523173,-0.0939079883548105,0.153442303906273,0.637119888241328
PLA2G1B,Phospholipase A2,Mental health,X29108.Ever thought that life not worth living,35959,0.0715658850446596,0.0628773495964538,-0.0516737201643898,0.194805490253709,0.255081434756626
PLA2G1B,Phospholipase A2,Mental health,X29109.Ever contemplated self-harm,35964,0.0943249570463665,0.089488441690756,-0.0810723886675153,0.269722302760248,0.291896325993848
PLA2G1B,Phospholipase A2,Mental health,X29111.Ever self-harmed,35976,0.205597060555436,0.157337034299495,-0.102783526671574,0.513977647782446,0.191345089833761
PLA2G1B,Phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35977,0.0598699238700863,0.0945381726359567,-0.125424894496389,0.245164742236561,0.526564990527573
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36654,-0.0709632052751561,0.0579169180871098,-0.184480364725891,0.0425539541755791,0.220513610070713
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36654,0.004362115476506,0.0447822304555344,-0.0834110562163415,0.0921352871693535,0.92240538358266
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36654,-0.0832716586317712,0.0557064640176367,-0.192456328106339,0.0259130108427967,0.134998156381702
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36654,-0.131780521487029,0.0918826920690495,-0.311870597942366,0.0483095549683079,0.151546679267533
PLA2G1B,Phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35966,0.0927367576098489,0.053748720563001,-0.0126107346936331,0.198084249913331,0.0845016640448169
PLA2G1B,Phospholipase A2,Health and medical history,X29153.Pain or discomfort today,35980,-0.0858402955144748,0.0490657312732892,-0.182009128810122,0.010328537781172,0.0802469179467146
PLA2G1B,Phospholipase A2,Mental health,X29154.Anxiety or depression today,35980,0.0660110433799647,0.0653188044950257,-0.0620138134302857,0.194035900190215,0.312242090638015
PLA2G1B,Phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,35806,-0.0086467441096759,0.0483638777230728,-0.103439944446899,0.0861464562275468,0.858111419057609
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35963,0.000940623154916515,0.0112219973824848,-0.0210544917147537,0.0229357380245867,0.933202155496716
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35963,0.0302658657833069,0.0116046962022602,0.00752066122687683,0.053011070339737,0.00912380626168563
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35963,-0.0653370663614827,0.0123147877631258,-0.0894740503772093,-0.041200082345756,1.15588724518736e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35963,0.0503510383990335,0.0171007113663092,0.0168336441210674,0.0838684326769996,0.00324611267005042
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35963,0.0461615222978113,0.0341348399591534,-0.0207427640221294,0.113065808617752,0.176311732106392
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35963,0.0122048483279629,0.0124746284695883,-0.0122454234724302,0.0366551201283559,0.327921678053579
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35958,0.0105162927306019,0.01312740201858,-0.015213415225815,0.0362460006870187,0.423102666970281
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35958,0.00168032629539219,0.0205680619424729,-0.0386330751118547,0.0419937277026391,0.934890762234999
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35958,-0.111327278250156,0.0236866392055783,-0.15775309109309,-0.0649014654072228,2.64888170629567e-06
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35958,0.05149581602089,0.0289627237061287,-0.00527112244312227,0.108262754484902,0.0754446134526719
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35958,-0.0453690420287921,0.0474324808881193,-0.138336704569506,0.0475986205119216,0.338852449624493
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35958,0.0306624637898751,0.0190593770104876,-0.00669391515068065,0.0680188427304309,0.107705988152555
PLA2G1B,Phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,35782,-0.0513187369535445,0.059670668983421,-0.16827324816105,0.0656357742539607,0.38979963211596
PLA2G1B,Phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,35917,0.105510438939911,0.0562182821540233,-0.00467739408197486,0.215698271961796,0.060585358595882
PLA2G1B,Phospholipase A2,Mental health,X29173.Frequency of feeling left out,35890,0.129923220476555,0.0582805006398035,0.0156934392225404,0.24415300173057,0.0258260177023474
PLA2G1B,Phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,35923,0.123810221855294,0.0599453884026885,0.00631726058602401,0.241303183124563,0.0389218306471602
PLA2G1B,Phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35973,-0.0258799629703838,0.048074101778973,-0.120105202457171,0.0683452765164033,0.590362173158608
PLA2G1B,Phospholipase A2,Mental health,X29176.Ability to make it through stressful events,35973,0.0594234149034721,0.0465835896929767,-0.0318804208947622,0.150727250701706,0.202126621163246
PLA2G1B,Phospholipase A2,Mental health,X29177.Quick recovery from stressful events,35973,-0.0364548135691987,0.04781766060503,-0.130177428355058,0.0572678012166601,0.445862809485836
PLA2G1B,Phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,35973,0.0937375069523533,0.0468936828832798,0.00182588850112493,0.185649125403582,0.0456518542296395
PLA2G1B,Phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,35973,-0.0800709208725307,0.0475162082052574,-0.173202688954835,0.0130608472097739,0.0920061010996478
PLA2G1B,Phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35973,0.0824820473444088,0.0468893713585208,-0.00942112051829201,0.17438521520711,0.0786058037295328
PLA2G1B,Phospholipase A2,Mental health,X29181.General happiness,35933,0.0733319439696826,0.0482955871271565,-0.021327406799544,0.167991294738909,0.128957118823335
PLA2G1B,Phospholipase A2,Mental health,X29182.Belief that own life is meaningful,35833,0.000980831853837188,0.0488343664657657,-0.0947345264190637,0.096696190126738,0.983976224720726
PLA2G1B,Phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34911,-0.0300217008461627,0.0457089789576418,-0.119611299603141,0.0595678979108153,0.511332865403523
PLA2G1B,Phospholipase A2,Health and medical history,X2946.Father's age,33582,0.0206463692672199,0.0100082311417975,0.00103023622929682,0.0402625023051429,0.0391701393937031
PLA2G1B,Phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,35596,-0.0221306811015784,0.00878874658755522,-0.0393566244131867,-0.00490473778997022,0.0118221168115444
PLA2G1B,Phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51843,0.00339119244568292,0.00343996355429881,-0.00335113612074274,0.0101335210121086,0.324230630636517
PLA2G1B,Phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51844,0.0115162876477406,0.00368945268313892,0.00428496038878834,0.0187476149066929,0.00180208933660908
PLA2G1B,Phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51844,-0.00477719392649829,0.00388793582341374,-0.0123975481403892,0.00284316028739264,0.219188335739283
PLA2G1B,Phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51844,0.0024500721880585,0.00381498990968384,-0.00502730803492183,0.00992745241103882,0.52073508849863
PLA2G1B,Phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51844,-0.0157890183067221,0.00340296117009929,-0.0224588222001167,-0.00911921441332749,3.50668056524488e-06
PLA2G1B,Phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51844,-0.0236055566585312,0.00341664757956585,-0.0303021859144803,-0.0169089274025822,5.0074646896453e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51844,-0.0173841121706719,0.00332640312207626,-0.0239038622899414,-0.0108643620514024,1.74618172696154e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51844,0.0238480214352639,0.00348120820557166,0.0170248533523435,0.0306711895181844,7.54285764851806e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30080.Platelet count,51844,-0.00341689568340786,0.0034006257855016,-0.010082122222991,0.00324833085617528,0.315011144747767
PLA2G1B,Phospholipase A2,Blood and urine assays,X30090.Platelet crit,51844,-0.00139410961471719,0.00346053257639784,-0.00817675346445695,0.00538853423502257,0.687055038558233
PLA2G1B,Phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51844,0.00381675890303201,0.003219523924439,-0.00249350798886843,0.0101270257949324,0.235830302676298
PLA2G1B,Phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51844,-0.00662993886136909,0.00330720218738733,-0.0131120551486483,-0.000147822574089925,0.0450070072828713
PLA2G1B,Phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51807,-0.0146266969246359,0.00334169610598026,-0.0211764212923572,-0.00807697255691459,1.20833922610002e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30130.Monocyte count,51807,-0.00134044544018357,0.00335164117171477,-0.00790966213674452,0.00522877125637738,0.689206572876777
PLA2G1B,Phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51807,0.00875012611912159,0.00340025744274007,0.00208562153135105,0.0154146307068921,0.0100774496701156
PLA2G1B,Phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51807,0.000299022964995458,0.00323997102567139,-0.00605132024532047,0.00664936617531139,0.926466949064509
PLA2G1B,Phospholipase A2,Blood and urine assays,X30160.Basophill count,51807,0.00515493833144938,0.0274225715763726,-0.0485933019582409,0.0589031786211397,0.850892734445777
PLA2G1B,Phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51807,0.115918376741986,0.129896069882271,-0.138677920227265,0.370514673711237,0.37219143795549
PLA2G1B,Phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51808,-0.0163746124824776,0.00330936151700837,-0.022860961055814,-0.00988826390914122,7.55171307534899e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51808,-0.00385756577164459,0.00331445300334371,-0.0103538936581982,0.00263876211490908,0.244491922188119
PLA2G1B,Phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51808,0.0153655351839656,0.00326310357513313,0.00896985217670471,0.0217612181912266,2.50531665464182e-06
PLA2G1B,Phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51808,-0.000676795192145865,0.0032092241830819,-0.00696687459098638,0.00561328420669465,0.832974496043816
PLA2G1B,Phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51808,-0.00544945176236947,0.00335484560828613,-0.0120249491546103,0.00112604562987134,0.104314184058226
PLA2G1B,Phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51806,0.108385873568246,0.130306818155742,-0.147015490017008,0.363787237153501,0.40554486381505
PLA2G1B,Phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51453,-0.0288532297282419,0.00352644451551823,-0.0357650609786576,-0.0219413984778261,2.93693231699219e-16
PLA2G1B,Phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51453,-0.0268063924998124,0.00355727816640576,-0.0337786577059677,-0.0198341272936572,5.03957473769115e-14
PLA2G1B,Phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51453,0.00104743980849221,0.00333566755087839,-0.00549046859122943,0.00758534820821386,0.753514752360392
PLA2G1B,Phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51453,-0.0141755579251848,0.00335665658639697,-0.0207546048345228,-0.00759651101584672,2.41877179797215e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51453,-0.0098719645474016,0.00347306893400431,-0.01667917965805,-0.00306474943675316,0.004481034904493
PLA2G1B,Phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51453,-0.0267578702864781,0.00357349049160113,-0.0337619116500163,-0.0197538289229399,7.25276663029217e-14
PLA2G1B,Phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51453,-0.025262458471582,0.00358631222477377,-0.0322916304321386,-0.0182332865110254,1.91914060273996e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,37144,0.0300652888192805,0.00555399609057738,0.0191794564817489,0.0409511211568122,6.35617394752512e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51901,0.0102621434864662,0.0035916181796562,0.00322257185434001,0.0173017151185923,0.00427710275166884
PLA2G1B,Phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51854,-0.0146673971121341,0.00335592829785293,-0.0212450165759258,-0.00808977764834231,1.24446415245996e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51867,-0.036301707077162,0.00346329913002908,-0.043089773372019,-0.029513640782305,1.1943085277792e-25
PLA2G1B,Phospholipase A2,Blood and urine assays,X30600.Albumin,49681,0.00170340107180102,0.00354619484155733,-0.00524714081765135,0.00865394296125339,0.630986256058321
PLA2G1B,Phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,51424,-0.00946439692870119,0.00349689162424843,-0.0163183045122281,-0.00261048934517426,0.00680436326125748
PLA2G1B,Phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,51409,-0.0249344945521094,0.00377156944391847,-0.0323267706621896,-0.0175422184420292,3.89715665492628e-11
PLA2G1B,Phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,49619,-0.0479546837084519,0.00382899034843223,-0.0554595047913791,-0.0404498626255247,7.40089671073377e-36
PLA2G1B,Phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,51258,-0.0199396545191882,0.00327574876356086,-0.0263601220957674,-0.0135191869426089,1.16856124395058e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,51342,-0.0101635959823484,0.00348338346150316,-0.0169910275668946,-0.00333616439780215,0.00352926940907551
PLA2G1B,Phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,49839,0.00582216419171737,0.00356631567230982,-0.00116781452600988,0.0128121429094446,0.10257994194404
PLA2G1B,Phospholipase A2,Blood and urine assays,X30670.Urea,51406,0.0837926591867235,0.0033750607515701,0.0771775401136461,0.0904077782598009,2.777148213193e-134
PLA2G1B,Phospholipase A2,Blood and urine assays,X30680.Calcium,49672,0.0176651144841413,0.00351362237577589,0.0107784146276205,0.024551814340662,5.00708305316284e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30690.Cholesterol,51428,-0.0302371449485195,0.00329539158164327,-0.0366961124485403,-0.0237781774484987,4.8617976937104e-20
PLA2G1B,Phospholipase A2,Blood and urine assays,X30700.Creatinine,51414,0.190722971640643,0.00406473627185574,0.182756088547806,0.19868985473348,0
PLA2G1B,Phospholipase A2,Blood and urine assays,X30710.C-reactive protein,51345,-0.0185375415681976,0.00365884565619774,-0.0257088790543452,-0.0113662040820501,4.08366607977101e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30720.Cystatin C,51432,0.136454352833257,0.00383290955988009,0.128941850095892,0.143966855570622,3.26719700265968e-270
PLA2G1B,Phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,51411,-0.038712566600535,0.00397721144148834,-0.0465079010258521,-0.0309172321752178,2.39632280932381e-22
PLA2G1B,Phospholipase A2,Blood and urine assays,X30740.Glucose,49648,-0.0504821185605035,0.00333376597698411,-0.0570162998753923,-0.0439479372456146,1.58313053523022e-51
PLA2G1B,Phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51296,-0.0214237545091693,0.00337015179547106,-0.0280292520282926,-0.0148182569900461,2.09767775382558e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,49660,-0.039163523028271,0.00396443880195801,-0.0469338230801088,-0.0313932229764333,5.77698887208473e-23
PLA2G1B,Phospholipase A2,Blood and urine assays,X30770.IGF-1,51318,0.0636091679415407,0.00346894997590619,0.0568100259887646,0.0704083098943169,1.45539434344175e-74
PLA2G1B,Phospholipase A2,Blood and urine assays,X30780.LDL direct,51373,-0.0198477046002722,0.00329224470142552,-0.0263005042150662,-0.0133949049854782,1.6790683631804e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,46799,0.011325761635014,0.00364602850350864,0.00417954576813705,0.0184719775018909,0.00189717514893365
PLA2G1B,Phospholipase A2,Blood and urine assays,X30810.Phosphate,49617,0.0232852760810562,0.00342783440062898,0.0165667206558234,0.030003831506289,1.12761619722903e-11
PLA2G1B,Phospholipase A2,Blood and urine assays,X30830.SHBG,49524,0.013445021828433,0.00455145579795293,0.00452416846444525,0.0223658751924207,0.00314028249924316
PLA2G1B,Phospholipase A2,Blood and urine assays,X30840.Total bilirubin,51327,0.0064563727926013,0.0035997295425084,-0.00059909711071517,0.0135118426959178,0.0728948572474222
PLA2G1B,Phospholipase A2,Blood and urine assays,X30850.Testosterone,51191,0.0316816227276055,0.00563581872587648,0.0206354180248876,0.0427278274303234,1.91566340449228e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30860.Total protein,49647,0.00542636087707752,0.00348150150763178,-0.00139738207788076,0.0122501038320358,0.119099817618506
PLA2G1B,Phospholipase A2,Blood and urine assays,X30870.Triglycerides,51399,-0.0139646217494731,0.00345834169528272,-0.0207429714722272,-0.00718627202671893,5.40958987013434e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30880.Urate,51394,0.0353041619505807,0.00412735819641192,0.0272145398856133,0.0433937840155481,1.26604285253806e-17
PLA2G1B,Phospholipase A2,Blood and urine assays,X30890.Vitamin D,50736,0.0270566083015113,0.00370437035724316,0.0197960424013147,0.0343171742017079,2.88855796291277e-13
PLA2G1B,Phospholipase A2,Physical measures,X3137.Number of measurements made,50101,0.0289923049980966,0.0331307394998665,-0.0359439444216418,0.093928554417835,0.38153592565406
PLA2G1B,Phospholipase A2,Physical measures,X3143.Ankle spacing width,42144,-0.0317823509714438,0.00593571606524803,-0.0434163544593299,-0.0201483474835577,8.72297387220606e-08
PLA2G1B,Phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42143,0.00991809387045923,0.00432655885808051,0.00143803850862143,0.018398149232297,0.0218992954507716
PLA2G1B,Phospholipase A2,Physical measures,X3146.Speed of sound through heel,42144,0.0153562335481147,0.00417939255665791,0.00716462413706519,0.0235478429591642,0.000239446415450221
PLA2G1B,Phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42144,0.0138504123504935,0.0042191487460463,0.00558088080824276,0.0221199438927443,0.00103060029394578
PLA2G1B,Phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),42124,0.0143059286908273,0.00424476107738555,0.00598619697915164,0.022625660402503,0.000753085928529743
PLA2G1B,Phospholipase A2,Health and medical history,X3526.Mother's age at death,42911,0.00146051215921803,0.00439780569013138,-0.00715918699343948,0.0100802113118755,0.739818461054685
PLA2G1B,Phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",33017,0.00583768281695021,0.00741438906285906,-0.00869451974625354,0.020369885380154,0.431122126812291
PLA2G1B,Phospholipase A2,Physical measures,X4100.Ankle spacing width (left),36286,-0.015782864465135,0.00807873168501041,-0.0316171785677554,5.14496374854033e-05,0.0507810411496168
PLA2G1B,Phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36284,0.0132647510271797,0.00582607756121001,0.00184563900720808,0.0246838630471513,0.0228261828951345
PLA2G1B,Phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),36286,0.0116723690323419,0.00558505554795671,0.000725660158346696,0.022619077906337,0.0366569727401345
PLA2G1B,Phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36286,0.0124908161919432,0.00566082951397983,0.00139559034454275,0.0235860420393437,0.0273760518648168
PLA2G1B,Phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36275,0.0116044344801075,0.00569286676440628,0.000446415621871197,0.0227624533383438,0.0415424861633842
PLA2G1B,Phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36286,0.0124890479246909,0.00566117083541504,0.00139315308727741,0.0235849427621044,0.0274072283658287
PLA2G1B,Phospholipase A2,Physical measures,X4119.Ankle spacing width (right),36273,-0.015835436094728,0.00790728890842473,-0.0313337223552405,-0.000337149834215518,0.0452512931941827
PLA2G1B,Phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36272,0.00840171958887821,0.00586723854316677,-0.00309806795572866,0.0199015071334851,0.152192656832963
PLA2G1B,Phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),36273,0.00732301801547564,0.00557296328089305,-0.00359999001507475,0.018246026046026,0.188876775145562
PLA2G1B,Phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36273,0.00746303361386884,0.00566815095548536,-0.00364654225888247,0.0185726094866201,0.187991588034103
PLA2G1B,Phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36261,0.00750257329786114,0.00570095384344619,-0.0036712962352934,0.0186764428310157,0.188206469069182
PLA2G1B,Phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36273,0.00746378867321788,0.00566815959980784,-0.00364580414240548,0.0185733814888412,0.187947595508232
PLA2G1B,Phospholipase A2,Physical measures,X4194.Pulse rate,36664,-0.033906230362219,0.00530112754135715,-0.044296440343279,-0.023516020381159,1.6834030568485e-10
PLA2G1B,Phospholipase A2,Physical measures,X4195.Pulse wave reflection index,36664,0.0095152839433033,0.00556353167618752,-0.00138923814202425,0.0204198060286308,0.0872496839846593
PLA2G1B,Phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,36656,0.0186090355160633,0.00613837890941286,0.00657781285361412,0.0306402581785125,0.00244044259116309
PLA2G1B,Phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,36664,-0.0383028466949296,0.00661544342636676,-0.0512691158106085,-0.0253365775792508,7.30619017228316e-09
PLA2G1B,Phospholipase A2,Physical measures,X4199.Position of pulse wave notch,36664,-0.024983056013655,0.00537922246762005,-0.0355263320501903,-0.0144397799771197,3.46531163198845e-06
PLA2G1B,Phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36664,-0.0411775215768043,0.00673575477770928,-0.0543796009411144,-0.0279754422124941,1.02145806883801e-09
PLA2G1B,Phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),36439,-0.162507103385687,0.130769613694384,-0.418815546226679,0.0938013394553056,0.21401647406137
PLA2G1B,Phospholipase A2,Physical measures,X4270.Volume level set by participant (left),36350,0.0532964925179513,0.0417623986887497,-0.0285578089119981,0.135150793947901,0.201928846809647
PLA2G1B,Phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),36442,0.0708699884338957,0.130855610494812,-0.185607008135936,0.327346985003727,0.588116929105184
PLA2G1B,Phospholipase A2,Physical measures,X4277.Volume level set by participant (right),36354,0.0436141209180545,0.0415636629215946,-0.037850658408271,0.12507890024438,0.29405762363884
PLA2G1B,Phospholipase A2,Cognitive function,X4288.Time to answer,36628,0.00142766046255305,0.00635772806570461,-0.011033486546228,0.0138888074713341,0.822331088026512
PLA2G1B,Phospholipase A2,Cognitive function,X4290.Duration screen displayed,36628,-0.00541997772864454,0.00594203220184876,-0.0170663608442681,0.00622640538697903,0.36172130821984
PLA2G1B,Phospholipase A2,Physical measures,X46.Hand grip strength (left),52458,-0.0153312360767698,0.00437481989115729,-0.0239058830634381,-0.00675658909010148,0.000458429956093112
PLA2G1B,Phospholipase A2,Physical measures,X47.Hand grip strength (right),52458,-0.0179443234480578,0.00431604824941291,-0.0264037780169071,-0.00948486887920854,3.22756853616237e-05
PLA2G1B,Phospholipase A2,Physical measures,X48.Waist circumference,52516,-0.0701432467201581,0.00815810619963376,-0.0861331348714403,-0.054153358568876,8.60216983154714e-18
PLA2G1B,Phospholipase A2,Health and medical history,X4803.Tinnitus,36480,-0.043256529434404,0.0471617387062701,-0.135693537298693,0.0491804784298855,0.359068341445949
PLA2G1B,Phospholipase A2,Working and living environment,X4825.Noisy workplace,36559,-0.085892437012879,0.0455045603790131,-0.175081375355745,0.0032965013299866,0.0591218492765051
PLA2G1B,Phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,36511,0.0513686128347143,0.0622520886808419,-0.0706454809797357,0.173382706649164,0.409299451998031
PLA2G1B,Phospholipase A2,Physical measures,X49.Hip circumference,52510,-0.023154944781923,0.00603256282072339,-0.0349787679105408,-0.0113311216533051,0.000124194530666829
PLA2G1B,Phospholipase A2,Physical measures,X50.Standing height,52466,-0.0330287646587787,0.00455422579030066,-0.041955047207768,-0.0241024821097894,4.22138688435252e-13
PLA2G1B,Phospholipase A2,Health and medical history,X5057.Number of older siblings,35609,0.0772764137063468,0.0456084447138666,-0.0121161379328317,0.166668965345525,0.0902442871038102
PLA2G1B,Phospholipase A2,Physical measures,X51.Seated height,52361,-0.0177226886211661,0.00396693546657094,-0.0254978821356452,-0.00994749510668709,7.94661451268632e-06
PLA2G1B,Phospholipase A2,Eye measures,X5181.Ever had eye surgery,34006,0.0131859719177266,0.0990681123795601,-0.180987528346211,0.207359472181664,0.894119201756604
PLA2G1B,Phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33994,0.0091060967219494,0.00693840055466185,-0.00449316836518783,0.0227053618090866,0.18943425190117
PLA2G1B,Phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33990,0.00813817034967803,0.00717143724465644,-0.00591784664984859,0.0221941873492047,0.256508223152689
PLA2G1B,Phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),33937,0.0130148358069002,0.00718200503140857,-0.00106189405466058,0.027091565668461,0.0700199411226196
PLA2G1B,Phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),33933,0.0150529804715029,0.00720042674479679,0.000940144051701168,0.0291658168913046,0.0366140514055743
PLA2G1B,Phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",33973,-0.12727860238701,0.0523972308558089,-0.229977174864395,-0.0245800299096242,0.0151685471197363
PLA2G1B,Phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),33973,-0.132857776842617,0.305394775397095,-0.731431536620923,0.465715982935688,0.663553644355805
PLA2G1B,Phospholipase A2,Eye measures,"X5201.logMAR, final (right)",33912,-0.00832949294325766,0.00688528085782271,-0.0218246434245902,0.00516565753807485,0.22642730953391
PLA2G1B,Phospholipase A2,Eye measures,X5202.Number of rounds to result (right),33973,-0.0781643256402429,0.0495520406276945,-0.175286325270524,0.0189576739900382,0.114758158494311
PLA2G1B,Phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",33969,-0.0314965282438558,0.0523858332922869,-0.134172761496738,0.0711797050090265,0.547704645801088
PLA2G1B,Phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),33969,-0.210541191894812,0.312171033165689,-0.822396416899563,0.401314033109939,0.500059527517852
PLA2G1B,Phospholipase A2,Eye measures,"X5208.logMAR, final (left)",33921,-0.0109918180962254,0.00694640745336444,-0.0246067767048197,0.00262314051236893,0.113623531950769
PLA2G1B,Phospholipase A2,Eye measures,X5209.Number of rounds to result (left),33965,0.0553179966182096,0.0490535943898945,-0.0408270483859837,0.151463041622403,0.259494947333405
PLA2G1B,Phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33766,0.00155756975773164,0.0068692485229275,-0.0119061573472063,0.0150212968626695,0.820630778235185
PLA2G1B,Phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33766,-0.00203247730427936,0.00674031929991798,-0.0152435031321186,0.0111785485235599,0.763014728990412
PLA2G1B,Phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),33766,-0.0105280932415741,0.00698736111213621,-0.0242233210213611,0.00316713453821283,0.131940044413044
PLA2G1B,Phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),33766,-0.00870159953332131,0.00688690957747608,-0.0221999423051744,0.0047967432385318,0.206467121223818
PLA2G1B,Phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33740,0.00195346261850771,0.00689878664677087,-0.0115681592091632,0.0154750844461786,0.777065348987914
PLA2G1B,Phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33740,-0.00331589627848696,0.00682768720041521,-0.0166981631913008,0.0100663706343269,0.627232925553971
PLA2G1B,Phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),33740,-0.00558695645479187,0.00688455115745882,-0.0190806767234112,0.00790676381382741,0.417104230958159
PLA2G1B,Phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),33740,-0.00478513661550819,0.00684209474821941,-0.0181956423220182,0.00862536909100186,0.484354229747941
PLA2G1B,Phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34682,0.0389743958624353,0.238043191225176,-0.42759025893891,0.505539050663781,0.869950516024035
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52448,-0.0268170388815301,0.0178735762788744,-0.061849248388124,0.00821517062506382,0.133530937379674
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52448,-0.0498257081791012,0.0208210076887487,-0.0906348832490486,-0.00901653310915376,0.0167166588803481
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52448,-0.099240248927735,0.0506071916885057,-0.198430344637206,-5.01532182639458e-05,0.0498916894868541
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52448,-0.0425108918146762,0.00813731779233772,-0.0584600346876581,-0.0265617489416942,1.76388947075682e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52448,0.0422136779144796,0.00754527865049816,0.0274249317595032,0.057002424069456,2.23409412089647e-08
PLA2G1B,Phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",39060,-0.00713075319054781,0.00990460540942657,-0.0265437797930239,0.0122822734119283,0.471576061873407
PLA2G1B,Phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",39060,-0.0243392115393741,0.0308723697362538,-0.0848490562224316,0.0361706331436834,0.430491334342968
PLA2G1B,Phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",39060,-0.0230085023950764,0.0191311006280269,-0.0605054596260091,0.0144884548358562,0.229129214221858
PLA2G1B,Phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",39060,-0.0257667670365854,0.0114989184434867,-0.0483046471858193,-0.0032288868873516,0.0250599860698289
PLA2G1B,Phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52520,0.00233070643616938,0.0171965865110996,-0.0313746031255858,0.0360360159979245,0.892191547306122
PLA2G1B,Phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52520,0.00233070643616938,0.0171965865110996,-0.0313746031255858,0.0360360159979245,0.892191547306122
PLA2G1B,Phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52520,-0.00160277330203654,0.0125449784699387,-0.0261909311031164,0.0229853844990433,0.898338285957001
PLA2G1B,Phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52520,-0.00279945138820116,0.0220852473527068,-0.0460865361995065,0.0404876334231042,0.899134093412954
PLA2G1B,Phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52520,0.0705010168112905,0.0511830883127549,-0.0298178362817091,0.17081986990429,0.168392861934012
PLA2G1B,Phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52520,0.0162128840304441,0.0363921513713802,-0.0551157326574611,0.0875415007183494,0.655958906182681
PLA2G1B,Phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52520,-0.0328908309597074,0.055195051351452,-0.141073131608553,0.0752914696891386,0.551246462890102
PLA2G1B,Phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52447,0.0209139196685991,0.0111329182396703,-0.000906600081154771,0.042734439418353,0.0603159909628226
PLA2G1B,Phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52447,0.0169259726840393,0.019657097910259,-0.0216019392200683,0.0554538845881469,0.389212760133904
PLA2G1B,Phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52447,-0.0124085346866874,0.0101840147326278,-0.0323692035626379,0.00755213418926307,0.22307170896154
PLA2G1B,Phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52447,-0.0252553728102031,0.0151249736757609,-0.0549003212146946,0.00438957559428828,0.0949760985900728
PLA2G1B,Phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52447,-0.0177938300469235,0.0152327032490015,-0.0476499284149665,0.0120622683211194,0.242764621677133
PLA2G1B,Phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52447,0.001841295134764,0.00857782476444851,-0.0149712414035551,0.0186538316730831,0.830036130647818
PLA2G1B,Phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37228,0.0842210550911321,0.0175973923237942,0.0497301661364955,0.118711944045769,1.72968336727843e-06
PLA2G1B,Phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37228,0.0180066703724058,0.0168043004739513,-0.0149297585565388,0.0509430993013504,0.283951579776933
PLA2G1B,Phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37228,0.0834960756451916,0.0243118499530312,0.0358448497372504,0.131147301553133,0.000596710149326988
PLA2G1B,Phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37228,-0.0247752061809265,0.0181847160526173,-0.0604172496440565,0.0108668372822035,0.173101192040477
PLA2G1B,Phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52395,-0.057125490620827,0.0300979143170182,-0.116117402682183,0.00186642144052875,0.0577097073238352
PLA2G1B,Phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52395,-0.00730722127758532,0.0375354129858202,-0.0808766307297929,0.0662621881746223,0.845648738796339
PLA2G1B,Phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52395,0.0272743750757413,0.0748912234318364,-0.119512422850658,0.174061173002141,0.715721957963865
PLA2G1B,Phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52395,-0.0395775367635423,0.0708528971488647,-0.178449215175317,0.0992941416482324,0.576448586099521
PLA2G1B,Phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52395,0.0326145352491238,0.0285955891565326,-0.0234328194976801,0.0886618899959278,0.254071100985393
PLA2G1B,Phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52395,-0.0182286087378918,0.0336847191386375,-0.0842506582496212,0.0477934407738376,0.588406747286759
PLA2G1B,Phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52395,-0.022709021077867,0.0140947897645678,-0.0503348090164199,0.00491676686068595,0.107157195519235
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35752,0.0281605024576117,0.0236205941476256,-0.0181358620717345,0.0744568669869579,0.233221888647438
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35752,-0.00747142547660354,0.0232725257747909,-0.0530855759951938,0.0381427250419867,0.748189009441151
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35752,0.0740467549618775,0.0328130830101875,0.00973311226190997,0.138360397661845,0.0240617070736686
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35752,-0.0337575838624502,0.0119538424404551,-0.0571871150457422,-0.0103280526791581,0.00475604070808424
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38923,0.014615325953241,0.010807383369318,-0.00656714545062227,0.0357977973571043,0.176294151874476
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38923,-0.0137682798097065,0.011962014003081,-0.0372138272557452,0.00967726763633226,0.24975883654677
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38923,0.000130870979017353,0.0105865575490927,-0.0206187818172044,0.0208805237752391,0.990137044581817
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38924,0.0296355203017013,0.0245861713526653,-0.0185533755495227,0.0778244161529252,0.228086759616247
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38924,0.00773549596101167,0.0147055757611655,-0.0210874325308726,0.036558424452896,0.598882349920362
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38924,-0.0499215592993877,0.0266187933044572,-0.102094394176124,0.00225127557734841,0.060762433246055
PLA2G1B,Phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52447,-0.0202244329108394,0.0221642405370126,-0.063666344363384,0.0232174785417053,0.361525158328997
PLA2G1B,Phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52447,0.00444154310704848,0.0178895119792969,-0.0306219003723734,0.0395049865864704,0.803922718050747
PLA2G1B,Phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52447,0.0636847211041305,0.0351988817478831,-0.00530508712172043,0.132674529329981,0.0704197113663406
PLA2G1B,Phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52447,0.00803056484124327,0.0199102154239563,-0.030993457389711,0.0470545870721975,0.686702527918847
PLA2G1B,Phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52447,0.00172824075846657,0.0204316172492313,-0.0383177290500267,0.0417742105669599,0.932590773369145
PLA2G1B,Phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52447,0.0369690396948067,0.0245996694698733,-0.011246312466145,0.0851843918557584,0.132896984692003
PLA2G1B,Phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52447,0.00803439487900087,0.00712898533524424,-0.00593841637807783,0.0220072061360796,0.259752136276116
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34269,0.0217964695683984,0.0182871703750916,-0.0140463843667812,0.0576393235035779,0.233350539453321
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34269,-0.0236681639959943,0.021911009984579,-0.0666137435657691,0.0192774155737805,0.280101295216495
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34269,0.0196286707536297,0.0163324212215221,-0.0123828748405536,0.0516402163478129,0.229482520903816
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34269,-0.000166597034929498,0.0145002831968434,-0.0285871521007426,0.0282539580308836,0.990833529683352
PLA2G1B,Phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52556,0.0121603716694245,0.00865997061879956,-0.00481317074342264,0.0291339140822716,0.160270859041669
PLA2G1B,Phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52556,0.0246085446492227,0.0285964940416215,-0.0314405836723554,0.0806576729708008,0.389497788959609
PLA2G1B,Phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52556,0.00215640713080602,0.0076258641992501,-0.0127902866997242,0.0171031009613362,0.777351422782825
PLA2G1B,Phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52556,-0.00954686059622139,0.00712592707535968,-0.0235136776639264,0.00441995647148357,0.180343917621839
PLA2G1B,Phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52556,-0.000884331409865382,0.0120657346419911,-0.024533171308168,0.0227645084884372,0.941573737325686
PLA2G1B,Phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52556,-0.00766045040684219,0.0108734099576491,-0.0289723339238344,0.0136514331101501,0.481120678777525
PLA2G1B,Phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52556,-0.0149750900582234,0.0076848425717207,-0.030037381498796,8.72013823491752e-05,0.0513485594339202
PLA2G1B,Phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52556,-0.0320072403168203,0.0249064355174357,-0.0808238539309943,0.0168093732973537,0.19877004598794
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45281,0.0337184961037997,0.00787920214345511,0.0182752599026277,0.0491617323049717,1.88417227006124e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45281,-0.0634488777138977,0.00773825265962151,-0.0786158529267558,-0.0482819025010395,2.59034034449698e-16
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45281,0.0347194790021127,0.0100291051486396,0.0150624329107792,0.0543765250934463,0.00053777584295776
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45282,-0.00453286452996654,0.0155634776571252,-0.035037280737932,0.0259715516779989,0.770863664102088
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45282,-0.000933875321852189,0.00887131872659599,-0.0183216600259803,0.0164539093822759,0.916163584214352
PLA2G1B,Phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52326,-0.00964098629561477,0.00815847320023816,-0.0256315937680816,0.00634962117685201,0.237330836308395
PLA2G1B,Phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52326,-0.00615240409421146,0.00641548584430919,-0.0187267563490575,0.00642194816063455,0.33757219466156
PLA2G1B,Phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52326,0.00252233897491815,0.00724142935494343,-0.011670862560771,0.0167155405106073,0.727602519690674
PLA2G1B,Phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52326,0.00996470113787814,0.0110950532254948,-0.0117816031840917,0.0317110054598479,0.369130117864215
PLA2G1B,Phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52349,-0.000642172560494698,0.00690705776684116,-0.0141800057835034,0.012895660662514,0.925925487312036
PLA2G1B,Phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52349,0.0523258000693406,0.00963137096226807,0.0334483129832951,0.071203287155386,5.60056633324357e-08
PLA2G1B,Phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52447,-0.00570473559961181,0.00706750086042239,-0.0195570372860397,0.00814756608681606,0.419571631393348
PLA2G1B,Phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52447,-0.0182592280837858,0.00886554763504305,-0.0356357014484702,-0.000882754719101434,0.0394503652988676
PLA2G1B,Phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52447,0.0503486066086687,0.0189170287163704,0.0132712303245827,0.0874259828927548,0.00778340466629755
PLA2G1B,Phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52447,0.0292886426346209,0.0173008774387104,-0.00462107714525148,0.0631983624144934,0.0904877058202568
PLA2G1B,Phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52447,0.049350701163327,0.0209552563050144,0.00827839880549886,0.0904230035211552,0.0185282104327927
PLA2G1B,Phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52447,-0.00357442492785333,0.0216370850023402,-0.0459831115324401,0.0388342616767334,0.8687887481705
PLA2G1B,Phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42144,0.0138506422473833,0.00421916209995084,0.00558108453147964,0.0221201999632869,0.00103043922670477
PLA2G1B,Phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,52074,-0.0350024267177744,0.0246427933232315,-0.083302301631308,0.0132974481957593,0.155506872832727
PLA2G1B,Phospholipase A2,Physical activities,X874.Duration of walks,49395,-0.0016010541730638,0.00330705555216622,-0.0080828830553096,0.00488077470918199,0.628296699676814
PLA2G1B,Phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51471,-0.069912269956057,0.0239418424093381,-0.11683828107836,-0.0229862588337543,0.00350274984446656
PLA2G1B,Phospholipase A2,Physical activities,X894.Duration of moderate activity,46625,-0.0264512814730537,0.0287370887723983,-0.0827759754669544,0.0298734125208469,0.357345822812298
PLA2G1B,Phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33385,-0.00508868075876709,0.00715759050426683,-0.0191175581471301,0.0089401966295959,0.477150583195374
PLA2G1B,Phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51395,0.018432244443766,0.0243777760798351,-0.0293481966727108,0.0662126855602428,0.449591943543127
PLA2G1B,Phospholipase A2,Physical activities,X914.Duration of vigorous activity,42234,0.00467407265663359,0.0038678440494408,-0.00290690168027038,0.0122550469935376,0.22689751003346
